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Membrane-bound organelles in eukaryotic cells form an interactive network to coordinate and 
facilitate cellular functions. The formation of close contacts, termed ―membrane contact sites‖ 
(MCSs), represents an intriguing strategy for organelle interaction and coordinated interplay. 
Emerging research is rapidly revealing new details of MCSs. They represent ubiquitous and 
diverse structures, which are important for many aspects of cell physiology and homeostasis. 
Here, we provide a comprehensive overview of the physiological relevance of organelle contacts. 
We focus on mitochondria, peroxisomes, the Golgi complex and the plasma membrane, and 
discuss the most recent findings on their interactions with other subcellular organelles and their 
multiple functions, including membrane contacts with the ER, lipid droplets and the 
endosomal/lysosomal compartment.  
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Membrane-bound organelles in eukaryotic cells do not function as isolated entities. They form a 
―social network‖ within the cell and cooperate to coordinate and facilitate metabolic and other 
cellular functions. It is now evident that a coordinated interplay is often mediated by inter-
organelle membrane contacts, which bring organelles in close apposition [1]. This review was 
written in times of the COVID-19 pandemic, where we more than ever value social contacts, and 
appreciate their importance for efficient communication and the maintenance of production 
chains. We also understand that ―social distancing‖ and ―self-isolation‖ are mechanisms for 
protection. In analogy, organelles can form so called membrane contact sites (MCSs), which 
facilitate the transfer of metabolites, lipids and proteins to fuel cooperative metabolic pathways, 
to efficiently exchange information for cellular signalling/communication, or to hold organelles 
in a specific location within the cell. Many membrane contacts require dynamic regulation, as 
they are not permanently required and need to be adapted to the changing needs of the cell. Thus, 
organelles can keep ―social distance‖, and can even ―self-isolate‖. An intriguing example is the 
assembly of actin filament cages at damaged mitochondria to prevent contact and fusion with 
neighbouring populations [2].  
The research field of membrane contacts and organelle interaction is rapidly growing [3–5]. It is 
becoming clear that many, if not all, organelles form MCSs [6,7]. MCSs are formed by 
interacting proteins (or lipids) which function as tethers to bridge the opposing organelle 
membranes. The term ‗MCS‘ generally describes a region of physical interaction between two 
organelles, which impacts on organelle function. However, ‗non-classical‘ types of MCSs exist 
(e.g. between internal organelle membranes), and considerable variation in their composition, 
size, distance between organelles and stability have been described [3]. Guidelines have been 
delineated to define MCSs and their tethers [8,9], and new approaches are being developed to 
study and quantify MCSs, and to distinguish them from stochastic interactions [10–12]. 
Consequently, new contact sites are being discovered and the number of tethers and proteins 
associated with MCS is constantly expanding [9]. MCS resident proteins include molecular 
tethers, proteins involved in the transfer of small molecules (e.g. ions and lipids), as well as 
regulatory components. Many tether proteins appear to have additional functions (e.g. in lipid 
transfer) and localize to multiple MCSs (see Table 1). Current research is now focusing on the 
regulation of MCSs and their physiological functions, and it is becoming evident that MCSs are 
central to cell physiology and impact on human health and disease, thus changing our current 
understanding of disease pathology [13–19].  
The ER has long been in the focus of MCS research [4,20–22], but MCS between other 
subcellular organelles have also been discovered including mitochondria, peroxisomes, lipid 
droplets and lysosomes [23–27]. In this review, we will provide a comprehensive overview of 
the physiological relevance of organelle contacts. We will place mitochondria, peroxisomes, the 
Golgi complex and the plasma membrane in the centre of our review, and will summarize and 
discuss recent findings on their interaction with other subcellular organelles and their 
physiological role, including membrane contacts with the ER, lipid droplets and the 
endosomal/lysosomal compartment. We particularly focus on organelle interactions in 














2. Mitochondrion-organelle interactions and their physiological relevance 
2.1 Mitochondria-ER contacts 
The endoplasmic reticulum (ER) is one of the most extensively studied and largest organelles in 
the cell. The ER is involved in many functions including protein and membrane lipid synthesis 
and transport, requiring it to communicate with other intracellular organelles including the Golgi 
apparatus, lysosomes, peroxisomes and mitochondria [4,28,29]. ER-mitochondria connections 
were first reported over 60 years ago in Fundulus heteroclitus by electron microscopy [30] and 
have been extensively characterized since. Electron tomography studies have shown that the ER-
mitochondria distance in mammalian cells can be as close as ∼10nm at the smooth ER and 
∼25nm at the rough ER [31], forming contacts at specialized domains called mitochondria-ER 
association membranes (MAMs), which are essential for cooperative functions like lipid transfer 
and calcium signalling [32]. 
ER-mitochondria tethering is best studied in the yeast system, where studies show that four 
proteins (Mmm1, Mdm10, Mdm12 and Mdm34) form a complex which connects the ER and 
mitochondria, which is often referred to as ERMES (ER-mitochondria encounter structures) 
[33,34]. ER-mitochondria contacts are reported to be important for multiple cellular functions, 
such as mitochondrial fission, Ca
2+ 
signalling, lipid transport, energy metabolism, phospholipid 
synthesis, autophagy, immune signalling, glucose homeostasis, insulin signalling and 
inflammation [4,13] (Table 1; Fig. 1). ER-mitochondria contacts are crucial for normal 
physiological cell function, with miscommunication between the ER and mitochondria leading to 
diseases such as metabolic and neurodegenerative disorders [14,29,35]. For example, it was 
recently shown that increasing ER-mitochondria contacts with an artificial linker results in 
extended lifespan in a Drosophila model of Alzheimer's disease, suggesting modulating ER-
mitochondria contact sites may be a new step to therapeutic strategies [36]. 
 
2.1.1 Mitochondria-ER contacts regulate mitochondrial fission 
Mitochondrial division is essential for cellular functions such as homeostasis of metabolism, 
mitochondrial quality control, and to regulate size, number, morphology and distribution of 
mitochondria in cells [37]. Impairment or dysfunction in mitochondrial fission has been directly 
linked to neurodegenerative and metabolic disorders [38,39]. Mitochondrial fission (as well as 
peroxisomal fission) (see 3.1.1) is controlled by large GTPases such as Dynamin related protein-
1 (DRP1/DNML1). DRP1 is known to be recruited to mitochondria/peroxisomes by adaptor 
proteins such as MFF (Mitochondrial Fission Factor) [40]. ER-mitochondria contacts are 
important in the selection of mitochondrial fission sites [41], and mitochondrial fission and 
fusion events are spatially coordinated at ER-mitochondria MCSs [42]. Fission involves 
oligomerization of DRP1 at ER-mitochondria constriction sites, where DRP1 forms ring-like 
structures around the mitochondrion. ER tubules wrap around the mitochondria at constriction 













cut the membrane at the constriction site which leads to the fission of mitochondria [41,43]. In 
addition, to ensure daughter mitochondria both inherit mitochondrial DNA (mtDNA), mtDNA 
nucleoids are recruited to ER-mitochondria contacts prior to constriction or DRP1 recruitment 
[44]. These contacts promote mtDNA synthesis in an ER tubule-dependent manner, resulting in 
spatial and temporal coordination of mitochondrial division and mtDNA replication for accurate 
segregation of nascent mtDNA.  
Actin-mediated contractile forces at ER-mitochondria contact sites also promote fission, 
enhancing the recruitment of DRP1 and driving initial membrane constriction as a result of actin 
polymerization mediated by the ER-localized protein inverted formin 2 (INF2) and the 
mitochondria-anchored actin nucleator Spire1C [45,46] (Table 1). INF2 knockdown leads to 
elongated mitochondria, as a result of reduced fission, while its overexpression causes actin 
filament aggregation at ER-mitochondria contacts, which is the site of INF2 activation [47]. 
Mutations in INF2 lead to Charcot-Marie-Tooth disease [48], suggesting deregulation of 
mitochondrial fission at ER-mitochondria contacts could play a role in the pathophysiology of 
this disease. Interestingly, a recent study has proposed that PI(4)P-containing vesicles derived 
from the trans-Golgi network are also recruited to ER-mitochondria fission sites to facilitate the 
final scission of the mitochondrial membrane. This, in addition to the presence of lysosomes at 
mitochondria sites of fission (see 2.2.1) raises the possibility that mitochondrial fission may be 
regulated by three- or even four-way contact sites [49]. 
A recent study has implicated components of the ER-associated degradation (ERAD) quality 
control pathway in regulating mitochondrial dynamics via ER-mitochondria contacts [50]. In 
brown adipocytes, loss of the ER-resident ERAD protein Sel1L prevents the mitochondrial 
fission usually stimulated by cold stress, resulting in enlarged ‗megamitochondria‘ with impaired 
metabolic functions. Counterintuitively for a fission defect, loss of Sel1L actually increased ER-
mitochondrial contacts, via reduced degradation of the MAM protein SigmaR1, leading to long 
ER tubules that even appeared to perforate mitochondria, and may represent stalled fission or 
accelerated fusion events. Therefore, depending on the context and proteins involved, ER-
mitochondria contacts can either positively or negatively induce mitochondrial fission (Table 1). 
 
2.1.2 Mitochondria-ER contacts regulate Ca
2+
 signalling 
Calcium ions are one of the most ubiquitous secondary messengers in the cell and are involved in 
a complex and dynamic variety of physiological functions, which includes signal transduction, 
muscle contraction, secretion of proteins, secretion of hormones, gene expression, induction of 
various forms of cell death (necrosis, apoptosis and autophagy) and neuronal function [51]. Ca
2+
 
uptake and release are crucial functions of both mitochondria and the ER, meaning they must 
cooperate to facilitate signalling and maintain homeostasis. The inner mitochondrial membrane 
(IMM) has selective gated Ca
2+
 ion channels, which allows the Ca
2+
 ions to enter the 
mitochondrial matrix via the mitochondrial calcium uniporter (MCU, previously CCDC109A) 
[52]. The ER is the major site of Ca
2+













of approximately 1mM, which is relatively close to the extracellular concentration, although 
significant heterogeneity in Ca
2 +
 levels exists between different regions of the ER [51,53].  
In the resting state, cytosolic Ca
2+
 is maintained at approximately 100nM, depending on cell 
type. A wide variety of stimuli induce transient Ca
2+ 
influx into the cytosol to propagate 
signalling, which requires subsequent uptake and storage of excess Ca
2+
 to return to the 
homeostatic levels [32]. Mitochondrial accumulation of Ca
2+ 
following release of Ca
2 + 
from the 
intracellular reservoir of the ER, as well as local Ca
2+ 
signalling between the two organelles, 
requires close ER-mitochondria apposition [54] and involves the Ca
2+ 
release channel IP3R 
(1,4,5-trisphosphate receptor), a transmembrane protein located at the ER and Golgi membrane 
[55]. A recent study has shown IP3R has a role in maintaining ER-mitochondria contacts, 
independent of its Ca
2+
 transfer function. While the different isoforms of IP3R can all support the 
formation of ER-mitochondria contacts, IP3R isoform 2 is the most efficient at delivering Ca
2+
 to 
mitochondria from the ER [56] (Table 1; Fig. 1).  
Mechanistically, cooperative Ca
2 + 
transfer between the ER and mitochondria is facilitated by the 
cytosolic chaperone glucose-regulated-protein 75 (GRP75) which forms a tethering complex by 
simultaneously binding IP3R and the mitochondrial porin voltage-dependent anion channel 
(VDAC) in the OMM, with knockdown of GRP75 destroying the functional Ca
2+
 coupling 
between the ER and mitochondria [57] (Table 1). Physiologically, GRP75–mediated ER-
mitochondria tethering has recently been shown to promote regeneration of damaged axons in 
neurons by increasing mitochondrial Ca
2 + 
which in turn increases ATP production [58,59]. In 
mammalian neurons, PDZD8 has been proposed as an alternative ER-mitochondria tether that is 
required for the mitochondrial uptake of Ca
2+
 following its stimulated release from the ER in 
response to synaptic activation, to regulate cytosolic Ca
2+
 dynamics [60] (Table 1). However, 
despite initially being characterised as a functional orthologue of the yeast ERMES component 
Mmm1, there is increasing evidence that PDZD8 may be only distantly related to Mmm1 [61], 
and may in fact predominantly localise to ER-late endosome/lysosome contacts [62]. 
The role of ER-mitochondria MCSs in activity-dependent, responsive Ca
2+
 transfer raises the 
intriguing question of how these MCSs are regulated by external stimuli. A recent high-
throughput drug screen using split luciferase complementation as a quantitative readout of ER-
mitochondria contacts identified a number of G-protein coupled receptor (particularly β-
adrenergic receptor) agonists that increased the extent of ER-mitochondria contacts and thus 
mitochondrial Ca
2+
 uptake [63]. While this increase in contacts seemed to depend on a rise in 
cytosolic Ca
2+
 and an increase in actin polymerisation induced by receptor activation, how this 
mechanistically couples to ER-mitochondria contacts to regulate their formation remains to be 
seen. 
 
2.1.3 Mitochondria-ER contacts facilitate lipid transport 
The ER is known as the ―lipid hub‖ of the cell and participates in the transport of the majority of 
the lipids to other organelles, such as mitochondria, which cannot synthesize all of the lipids they 













Tethering of the ER and mitochondria is crucial for cell growth because it facilitates the transport 
of membrane lipids to mitochondria, which is essential for mitochondrial function as well as 
expansion of the mitochondrial network [66] (Fig. 1). In both yeast and mammals, the major 
lipids which are transported from ER to mitochondria are the phospholipids phosphatidylserine 
(PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylinositol (PI), as 
well as sphingolipids and sterols [67]. In yeast, phosphatidic acid is also transferred from the ER 
to mitochondria where it is used to synthesise cardiolipin, although if/how this transfer occurs in 
mammals is unclear [68]. 
Lipid metabolism occurs in numerous organelles, and the differential localisation of enzymes 
involved in the same biosynthetic pathway necessitates close contacts for the bidirectional 
transfer of intermediates between different compartments including the ER and mitochondria 
(see also 3.3.1). The experimental approaches to unravel the mechanism and molecules involved 
in the lipid transport between the ER and mitochondria for lipid metabolism have been 
extensively discussed [69]. The process of coordinated lipid synthesis between the ER and 
mitochondria varies between yeast and mammalian systems based on differences in synthesis 
pathways and enzyme localisations. Briefly, PS is produced in the ER – in mammals, this occurs 
from the precursors PC or PE in a reaction catalysed by PS synthase 1 (PSS1) and PS synthase 2 
(PSS2) respectively, whereas in yeast, PS synthesis is catalysed by Pss1 from CDP-DAG as a 
precursor. In both systems, ER-synthesised PS can then be transported to the mitochondria where 
it can be converted to PE by decarboxylation. Yeast, but not mammals, also possess a Golgi-
localised PS decarboxylase (Psdp2), meaning PE synthesis can occur in the Golgi as well as in 
mitochondria, in contrast to mammals [68] Newly-synthesised PE can be transferred back to the 
ER from the mitochondria and/or Golgi, where it can be converted to PC by methylation or 
distributed to the cellular membranes – notably, the inter-organelle PS-PE shuttle requires ATP 
in mammalian cells whereas it can proceed independently of ATP in yeast, suggesting different 
mechanisms of lipid transfer between the opposing membranes in the two systems [67,68,70].  
Lipid transport between organelles is well studied in the yeast system, where ERMES tethers are 
known to exchange the essential phospholipids [33], with the ERMES components Mmm1, 
Mdm12 and Mdm34 containing synaptotagmin-like mitochondrial lipid binding domains for 
non-vesicular lipid transport [71]. In yeast, the vacuole protein sorting-associated protein 13 
(Vps13) localises to numerous membrane contract sites, and can compensate for loss of ERMES 
subunits [70,72] (Table 1). VPS13 is conserved in mammalian cells and has two orthologues, 
VPS13A and VPS13C, which bind to ER-resident proteins via FFAT motifs and localise 
variously to ER-mitochondria (A), ER-lipid droplet (A & C) and ER-endosome (C) contact sites 
[73]. VPS13A contains a mitochondria-binding domain at the C-terminus, while its hydrophobic 
N-terminal domain can bind lipids and transport them between artificial membranes in vitro [73]. 
Loss of VPS13A results in neurodegeneration and misshaped erythrocytes, highlighting the 
importance of ER-mitochondria lipid transfer in physiological cell function (Table 1; Fig. 1). 
Additionally, the N terminal domain of the autophagy protein ATG2, which can transfer lipids 
between the ER and autophagosome membrane [74,75], is homologous to that of VPS13A [73], 
raising the possibility that ATG2 might also be involved in lipid transport at ER-mitochondria 













While lipid transport between the ER and mitochondria is less well defined in the mammalian 
system, evidence suggests the potential involvement of oxysterol-binding protein (OSBP)-related 
proteins ORP5 and ORP8 in PS shuttling in mammals. While ORP5 and ORP8 are known to 
facilitate transfer of PS from the ER to the PM in counter exchange with PI(4)P at ER-PM 
contact sites [76,77], ORP5/ORP8 have also been shown to localize to mitochondria-ER contacts 
where their depletion resulted in mitochondrial morphology and respiration defects [78]. Given 
the role of ORP5/ORP8 in PS exchange at ER-PM contact sites, and localization to 
mitochondria-ER contact sites, an intriguing possibility is that ORP5/ORP8 also function to 
transport PS at mitochondria-ER MCSs [79]. 
 
2.1.4 Mitochondria-ER contacts in immune signalling and inflammation 
Inflammation is the biological response in body tissues which is induced by harmful external 
stimuli such as pathogens or irritants. ER-mitochondria contact sites have a major role in a 
number of immune regulatory processes, such as leukocyte migration, lymphocyte activation, 
sensitization to cell death, B and T cell homeostasis, and modulation of the cytotoxic anticancer 
response, which are all affected by impairment of ER and mitochondrial functions (for a detailed 
review, see [80]).  
Inflammation in the body can be triggered by the activation of nucleotide-binding 
oligomerization domain-like receptors (NLRs), including NLRP3, which redistributes from the 
ER to the perinuclear region at the ER-mitochondria contact sites upon its activation [80]. This 
relocation of NLRP3, via docking to the mitochondrial anti-viral signalling protein (MAVS) in 
response to cellular stress (such as reactive oxygen species (ROS) production) or viral infection, 
promotes cytokine release, suggesting ER-mitochondria contact sites play a role in the initiation 
of inflammation [81] (Table 1; Fig. 1). For molecular details of ER-mitochondria contacts 
involved in the innate and adaptive immune system, see [82–85]. 
 
2.1.5 Mitochondria-ER contacts in autophagy 
Autophagy is the catabolic process that intrinsically degrades damaged cells and cytoplasmic 
proteins, prolonging their survival during nutrient starvation by engulfing, degrading and 
recycling intracellular components within specialized double-membrane vesicles known as 
autophagosomes. In recent years it has been shown that autophagosomes can form at ER-
mitochondria contact sites in mammals, and these MCSs are required for this type of 
autophagosome formation [86]. The integral ER protein vesicle-associated membrane protein-
associated protein B (VAPB) binds to the outer mitochondrial membrane (OMM) protein, 
protein tyrosine phosphatase interacting protein 51 (PTPIP51), forming one of the tethering 
complexes linking the ER and mitochondria [87] (Table 1; Fig. 1). Dysregulation of the VAPB-
PTPIP51 ER-mitochondria tether induces autophagy [88]. Overexpression of VAPB or PTPIP51 
increased ER-mitochondria contacts and impaired autophagosome formation – this is specifically 













reduce autophagosome formation, and required the ER-mitochondria Ca
2+
 transport function of 
the VAPB-PTPIP51 tether [88]. Autophagy is also reduced by the decreased transport of lipids 
from the ER to mitochondria, and subsequently the autophagosome, upon the disruption of ER-
mitochondria contacts [89].  
Recent studies have also highlighted the involvement of another MAM-localised pathway in 
autophagosome assembly, by showing that during starvation the cytosolic SNARE protein 
Syntaxin 17 (STX17) translocates to MAMs where it recruits the pre-autophagosome proteins 
ATG14 and ATG5 [86]. Later, ATG14 interacts with PI3KR4/VPS15 kinase and the ER protein 
Beclin1 (BECN1), which also relocate to MAMs upon starvation, inducing the lipid kinase 
activity of the PI3KC3 complex, the first step of phagophore formation [90]. Under resting 
conditions, the OMM anti-apoptotic protein Bcl-2 suppresses autophagy by interacting with 
Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) at the mitochondrial 
surface. In response to starvation, AMBRA1 dissociates from Bcl-2, freeing it to bind to BECN1 
at ER-mitochondria contact sites to induce autophagy [91]. In tumour cells, the interplay 
between apoptosis and autophagy induction can also be regulated by the presence of the tumour 
suppressor p53 and the promyelocytic leukemia (PML) p otein at MAMs. The interaction 
between p53 and PML in these ER-mitochondria appositions regulates the transfer of Ca
2+
 from 
the ER to the mitochondria, promoting Ca
2+
-dependent apoptosis [92,93]. The disruption of ER-
mitochondria contacts also leads to an increase in mTOR-independent AMPK-dependent 
autophagic flux, which in turn leads to ER-mitochondria Ca
2+ 
transfer inhibition, with AMPK 
present at the MAMs activating localized autophagy via BECN1 [94]. 
 
2.2 Mitochondria-Lysosome Contacts 
Mitochondria and lysosomes are intricately interrelated organelles, best highlighted by the 
common dysfunction of both organelles seen in disease [95–99]. The most obvious connection 
between lysosomes and mitochondria is the role of lysosomes in the degradation of mitochondria 
through autophagy. This involves the engulfment of a mitochondrion by an autophagosome, 
followed by fusion of the autophagosome with lysosomes to acidify and degrade mitochondrial 
components. Similarly, mitochondria-derived vesicles have been shown to fuse directly with 
lysosomes [100]. However, beyond the degradative connection of lysosomes and mitochondria, 
multiple lines of evidence suggest mitochondria-lysosome interplay is involved in the normal 
functioning of both organelles. For example, impairment of mitochondrial function through 
deletion of mitochondrial proteins, or chemical inhibition of the electron transport chain, causes 
impaired lysosomal function [97]. In addition, the lysosomal biogenesis factor TFEB promotes 
mitochondrial biogenesis, as well as increasing the expression of oxidative phosphorylation 
enzymes [101], and inhibition of lysosomal acidification results in diminished basal and maximal 
mitochondrial oxygen consumption rates [102]. This evidence indicates that the normal functions 
of lysosomes and mitochondria are tightly linked, and thus are likely highly coordinated. 
One possible mechanism of coordinating mitochondria and lysosome functions is through direct 













methodologies [6,103]. Importantly, many instances of lysosome-mitochondria contacts are seen 
to be independent of autophagy machinery, and temporal experiments visually tracing 
mitochondria and lysosomes have shown that lysosome-mitochondria contacts resolve without 
degradation of mitochondria [103]. This indicates that lysosome-mitochondria contacts are 
involved in the non-degradative functions of lysosomes and mitochondria. 
Lysosome-mitochondria contact has been shown to be regulated by Rab7, the master regulator of 
late endosome/lysosome dynamics. Rab7 is a GTPase whose localization to the late 
endosome/lysosome membrane is dependent on its nucleotide bound state. GDP-bound Rab7 
(Rab7-GDP) is inactive and cytosolic, whilst GTP-bound Rab7 (Rab7-GTP) is active and 
recruited to the late endosome/lysosome membrane [103]. Active membrane-bound Rab7-GTP 
acts by binding and recruiting Rab effector proteins to the lysosome which then function in 
facilitating lysosomal transport, fusion and organelle contact. Lysosomal dynamics are thus 
controlled through modulating the GTP bound state of Rab7, through guanine nucleotide 
exchange factors (GEFs) and GTPase activating proteins (GAPs). 
Rab7-GTP can promote the formation of lysosome-mitochondria contacts. Overexpression of a 
non-hydrolysable and constitutively active Rab7 mutant, Rab(Q67L)-GTP, increased both the 
number and duration of lysosome-mitochondria contacts when compared to overexpression of 
wild type (WT) Rab7 [103]. In turn, lysosome-mitochondria contact termination is regulated by 
the GTPase activating protein (GAP) TBC1D15, that is recruited to mitochondria by 
mitochondrial membrane protein FIS1 [104–106] (Table 1). The duration of lysosome-
mitochondria contact events in TBC1D15-/- cells are significantly lengthened. Similarly, mutants 
of TBC1D15 which lack GAP activity (TBC1D15(D397A) and TBC1D15(R400K)) also have 
significantly extended lysosome-mitochondria contact duration. Importantly, the role of 
TBC1D15 on lysosome-mitochondria contact termination is dependent on TBC1D15 
mitochondrial localization as both knockout of FIS1 and overexpression of a FIS1 mutant unable 
to recruit TBC1D15 to mitochondria (FIS1(LA)) result in an increase in the number and duration 
of lysosome-mitochondria contacts [103]. This indicates that TBC1D15 is acting on Rab7-GTP 
at sites of mitochondria-lysosome contact. 
Together, this data suggests a model of lysosome-mitochondria contact regulation whereby 
Rab7-GTP promotes contact formation between lysosomes and mitochondria, while 
mitochondrial TBC1D15 hydrolyzes Rab7-GTP to terminate lysosome-mitochondria contact. 
What remains to be answered in this model is the identification of the proteins that physically 
tether lysosomes and mitochondria. Presumably, Rab7-GTP acts to promote lysosome-
mitochondria contact through recruitment of an as-yet-unidentified effector protein which acts as 
a tether to mitochondria. Additionally, regulatory factors upstream of Rab7-GTP and TBC1D15 
remain to be determined. What physiological conditions and protein machinery promotes the 
formation of Rab7-GTP to initiate lysosome-mitochondria contact? What promotes the 
mitochondrial recruitment of TBC1D15 to terminate lysosome-mitochondria contact? And, 
above all, what function does lysosome-mitochondria contact serve in coordinating the normal, 














2.2.1 Mitochondria-lysosome contacts regulate mitochondrial dynamics 
Mitochondria are extremely dynamic organelles that continuously undergo fission and fusion 
events to reorganize the mitochondria network. How specific sites of mitochondria are 
designated for fusion or fission events is not clear, but mitochondrial MCSs with various 
organelles have been implicated in specifying fission sites. While many studies have focused on 
the contribution of the ER (see 2.1.1), lysosome contacts with mitochondria have also recently 
been shown to promote mitochondria fission [41] (Table 1). Lysosomes have been observed to 
localize to a large proportion of mitochondrial fission events (significantly higher than would be 
expected through random occurrence) [103,107], and are more prevalent than other organelles at 
mitochondrial fission events [103]. Furthermore, lysosomes were shown to be functionally 
involved at mitochondrial fission events as expression of non-hydrolysable Rab7(Q67L)-GTP 
resulted in decreased mitochondrial fission events, despite increased mitochondria-lysosome 
contact [103]. This suggests that lysosome-mitochondria contact termination is involved in 
promoting mitochondria fission events. However, the specific mechanism by which lysosomes 
contribute to mitochondrial fission is not known. 
Similarly, lysosome-mitochondria contact sites have been implicated in regulating a third type of 
mitochondrial dynamics, mitochondria-mitochondria contact (inter-mitochondrial contact). Inter-
mitochondrial contact is characterized by inter-mitochondria tethering and untethering without 
membrane fusion, ingeniously assessed using differential excitation of photoactivatable matrix 
probes in adjacent mitochondria. As with mitochondria fission events, lysosomes were observed 
at a large proportion of inter-mitochondrial untethering events. Lysosome recruitment to inter-
mitochondria contact sites was temporally coupled to untethering, whereby lysosome contact 
directly preceded mitochondria-mitochondria contact termination. Impairment of Rab7-GTP 
hydrolysis through expression of Rab7(Q67L)-GTP, TBC1D15(D397A) and FIS1(LA) extended 
the duration of inter-mitochondrial contact, implicating Rab7-GTP hydrolysis in inter-
mitochondrial contact termination [107]. Interestingly, the ER was also seen at a large proportion 
of inter-mitochondria untethering events (as well as fission and fusion events), indicating that 
mitochondria, the ER and lysosomes may act in a triple-MCS to regulate inter-mitochondria 
untethering events. While the functional significance of inter-mitochondria contact has not been 
elucidated, inter-mitochondria contact was shown to increase in response to mitochondrial 
dysfunction (rotenone) and increased mitochondrial respiration (nutrient starvation). These 
stimuli may offer clues into the potential function of inter-mitochondria contact, and the role 
lysosomes may play at these sites of contact.  
 
2.2.2 Mitochondria-lysosome contacts regulate cholesterol transport 
The endocytic pathway is involved in the transport of cholesterol from endocytosed low-density-
lipoprotein (LDL) to the ER. Direct transport of cholesterol between lysosomes and the ER 
occurs at lysosome-ER contact sites and requires the transmembrane endosomal protein NPC1, 
which has been shown to interact with ER resident proteins ORP5 and Gramd1b [108,109]. Cells 













impairment of lysosome-ER cholesterol transport in NPC1-deficient cells also resulted in 
cholesterol accumulation in mitochondria, implicating the involvement of mitochondria in 
cholesterol trafficking from lysosomes [109,112].  
Indeed, cholesterol transport from lysosomes to mitochondria has recently been shown to occur 
at lysosome-mitochondria contact sites as a compensatory mechanism for impaired lysosome-ER 
cholesterol transport [109]. Abolishment of lysosome-ER contacts through knockdown, 
knockout or chemical inhibition of NPC1 resulted in a reciprocal increase in lysosome-
mitochondria contacts. Lysosome-mitochondria contacts were shown to be dependent on the 
endosomal sterol binding protein STARD3 which relocates from ER-lysosome to mitochondria-
lysosome contact sites in NPC1-deficient cells [109] (Table 1; Fig. 1) . Depletion of STARD3 in 
NPC1 mutant cells prevented the mitochondrial accumulation of cholesterol, indicating that 
STARD3-mediated lysosome-mitochondria contacts facilitate the transport of cholesterol to 
mitochondria [112]. While lysosome-mitochondria contacts were shown to dramatically increase 
upon lysosome-ER contact inhibition, knockdown of STARD3 reduced lysosome-mitochondria 
contacts to levels below that of WT cells, where lysosome-ER contacts were intact [109]. This 
suggests that lysosome-mitochondria contacts may function in cholesterol trafficking even at 
steady states and are upregulated when there is an accumulation of cholesterol in lysosomes as a 
compensatory mechanism. 
While STARD3 appears to be required for lysosome-mitochondria tethering and cholesterol 
transport, how STARD3 anchors to the mitochondria is not known. Also unclear is if and how 
Rab7 may regulate STARD3-mediated lysosome-mitochondria contact. Interestingly, cholesterol 
accumulation has been shown to increase the proportion of membrane-associated Rab7 [113]. 
Furthermore, overexpression of Rab7 or stabilization of Rab7-GTP have been shown to reduce 
global cholesterol accumulation in NPC1 mutant cells [114,115]. While the effect of promoting 
Rab7-GTP in NPC1 mutant cells was linked to rescuing lysosome-ER contact, increased Rab7-
GTP during high cholesterol conditions may also act to rescue lysosomal cholesterol efflux 
through lysosome-mitochondria contact [115]. 
 
2.2.3 Mitochondria-lysosome contacts mediate iron transport 
Iron is essential for many cellular pathways, especially in mitochondria, where it is required for 
the biosynthesis of haem and iron-sulphur clusters [116]. However, iron is also extremely toxic 
to cells by producing hydroxyl radicals through the reaction of reduced Fe
2+
 with oxygen (Fenton 
reaction). Given the oxygen-rich cytosolic environment, the trafficking and storage of iron within 
the cell must be tightly controlled. The mechanism of iron uptake into cells through transferrin-
mediated endocytosis is well established and terminates with the release of iron from the 
transferrin receptor through acidification of the endocytic vesicle. Iron within the endolysosomal 
system is then transferred to mitochondria, the major iron storing compartment in the cell, where 
it is assembled into iron-sulphur clusters. This transfer of endocytosed iron from the 
endolysosomal system to mitochondria has been suggested to be mediated by 













Transferrin-positive endosomes have been shown to contact mitochondria using confocal 
microscopy, electron microscopy and STORM imaging [117,118]. Temporal studies of this 
interaction have demonstrated contact occurs in brief ―kiss and run‖ interactions. Contact 
between transferrin-positive endosomes and mitochondria was shown to mediate iron import into 
the mitochondria, as a mitochondrially-localized fluorescent metallosensor was immediately 
quenched following contact with transferrin-positive endosomes [117,118]. Divalent metal 
transporter 1 (DMT1) is a metal ion-proton cotransporter implicated in mediating iron trafficking 
between the endolysosomal compartment and mitochondria [119]. DMT1 localizes to the late 
endosome/lysosome membrane and is responsible for facilitating iron efflux from the 
endolysosomal compartment following endosome acidification [120]. Interestingly, DMT1 also 
localizes to the mitochondrial membrane and has been suggested to mediate mitochondrial iron 
uptake [121,122]. Studies have shown that iron uptake into mitochondria is decreased by DMT1 
inhibition, while DMT1 overexpression enhances mitochondrial iron uptake [122]. However, 
while these results clearly indicate to the involvement of DMT1 in iron exchange between the 
endolysosomal system and mitochondria, it is difficult to differentiate the role of endolysosomal 
and mitochondrial DMT1 as methods used to assess involvement of DMT1 affect both 
populations.  
A model of endosome/lysosome-mitochondria iron exchange has been proposed whereby 
endolysosomal DMT1, tasked with iron efflux, and mitochondrial DMT1, tasked with iron 
influx, associate at sites of endosome/lysosome-mitochondria contact to facilitate iron transport 
from endosomes to mitochondria (Table 1; Fig. 1). However, since DMT1 acts as a metal-H
+
 
cotransporter [119], and the mitochondrial inter membrane space is an acidic environment, it 
would be expected that DMT1 would be involved in iron efflux from mitochondria, rather than 
influx. One hypothesis put forward to reconcile this with the proposed function of mitochondrial 
DMT1 in iron import is that protons effluxed with iron by endolysosomal DMT1 may create 
local domains of high acidity at the endosome/lysosome-mitochondria interface creating a local 
inward proton gradient at the mitochondria membrane to allow mitochondrial iron influx. This is 
supported by evidence showing an increase in mitochondrial iron import following acute 
incubation of mitochondria in an acidic environment [122]. Alternatively, mitochondrial DMT1 
may function only in iron efflux from mitochondria and an as-yet-unidentified mitochondrial 
iron transporter is involved in iron influx. 
 
2.3 Mitochondria-lipid droplet contacts 
Lipid droplets are lipid storage organelles consisting of a triacylglycerol (TAG) and cholesterol 
ester neutral lipid core surrounded by a phospholipid monolayer studded with proteins to carry 
out structural, regulatory and enzymatic functions. Lipid droplets are emerging as a critical node 
in cell metabolism through their actions as both energy-rich fuel reservoirs for cells to tap into 
during nutrient depletion conditions, as well as a warehouse for lipid materials for use during cell 
growth and membrane expansion. Mitochondria also are central players in cell metabolism, 
housing the chemical reactions involved in β-oxidation, the citric acid cycle and oxidative 













anabolic processes as many citric acid cycle intermediates serve as substrates for biosynthetic 
processes including fatty acid, sterol, amino acid and nucleic acid production. Given the central 
role of both lipid droplets and mitochondria in metabolism, specifically in metabolism related to 
lipids, it makes sense for a highly coordinated system of communication to exist between these 
organelles. 
 
2.3.1 Mitochondria-lipid droplet contacts promote lipid metabolism 
Under nutrient depletion growth conditions (e.g. starvation or hibernation), where carbohydrate 
availability is reduced, cellular metabolism is remodeled to enhance the use of stored fatty acids 
for fuel [123]. This remodeling involves the mobilization of fatty acids stored as TAGs from 
lipid droplets and their subsequent uptake into mitochondria where they are metabolized for ATP 
production. Membrane contact between lipid droplets and mitochondria has been proposed as an 
ideal mechanism to facilitate efficient and direct exchange of fatty acids between lipid droplets 
and mitochondria for metabolism while preventing release of toxic free fatty acids into the 
cytosol.  
Fatty acids, initially localized to lipid droplets under nutrient-rich conditions, are observed to 
redistribute to mitochondria following nutrient depletion [124,125]. The transport of lipids 
between these two organelles is thought to occur at mitochondria-lipid droplet contact sites due 
to the increase in these MCSs during starvation [6,124]. While the tethering and lipid transfer 
machinery involved in this process are not well understood, the SNARE protein SNAP23 has 
been implicated in mediating mitochondria-lipid droplet contact related to lipid metabolism 
(Table 1). Knockdown of SNAP23 resulted in decreased mitochondria-lipid droplet contact as 
well as a decrease in β-oxidation of a radiolabeled fatty acid substrate, suggesting mitochondria-
lipid droplet contacts promote mitochondrial β-oxidation under conditions promoting lipolysis 
[126]. However, the mechanism of how SNAP23 mediates mitochondria-lipid droplet contact, 
such as if SNAP23 itself acts directly as a lipid droplet-mitochondria tether, has not been 
determined. Furthermore, while a specific signaling pathway linking the cell‘s nutrient status to 
changes in mitochondria-lipid droplet contact has not been well characterized, AMPK, a critical 
sensor of cellular energy status activated upon nutrient depletion to promote metabolic functions 
such as β-oxidation and lipolysis, has been implicated in regulating mitochondria-lipid droplet 
contact [124] (Table 1).  
 
2.3.2 Mitochondria-lipid droplet contacts promote lipid droplet expansion and biogenesis 
Less intuitive is the potential role of mitochondria-lipid droplet contact in lipid droplet expansion 
and biogenesis. While the mechanics of lipid droplet biogenesis are still being elucidated, the 
prevailing hypothesis is that neutral lipids (such as TAG and sterol-esters), produced by ER 
resident enzymes, concentrate within the leaflet of the ER phospholipid bilayer before budding 
from the ER as a nascent lipid droplet [127]. Lipid droplets are then able to grow through either 













Additionally, some evidence suggests that lipid droplets are also capable of locally synthesizing 
TAG independent of the ER [128]. The potential involvement of other organelles in this process 
is still unclear, however recent work has implicated the mitochondria in lipid droplet expansion 
and biogenesis [129–131]. 
Mitochondria isolated from the lipid droplet-associated fraction of brown adipose tissue (BAT), 
a key site of fatty acid storage and thus lipid droplet biogenesis, are shown to have a decreased 
capacity for fatty acid oxidation compared to non-lipid droplet-associated mitochondria [129], in 
contrast to lipid droplet-associated mitochondria in lipid-metabolising tissues [126]. 
Additionally, stimulation of fatty acid oxidation through cold exposure in BAT results in 
decreased mitochondria-lipid droplet contact [129], suggesting that mitochondria-lipid droplet 
contact does not contribute to lipid oxidation in BAT. Additionally, in white adipose tissue 
(WAT), mitochondrial mass has been found to be significantly higher in differentiating 
adipocytes than in mature adipocytes [132]. As WAT differentiation involves the rapid 
accumulation of lipids and production of lipid droplets, the correlation of increased 
mitochondrial mass during this time suggests mitochondria contribute to lipid droplet biogenesis. 
Further evidence supporting the role of mitochondria-lipid droplet contact in lipid droplet 
expansion comes from work identifying specific mitochondria-lipid droplet tethers. 
DGAT2, the enzyme responsible for catalyzing the final step in TAG synthesis, is required for 
lipid droplet biogenesis and expansion. DGAT2 is seen to localize to the ER, where it is 
specifically enriched in the mitochondria-ER contact site, as well as to lipid droplets following 
treatment with exogenous lipids [128,133]. DGAT2 localized to lipid droplets interacts with ER 
protein FATP1 to facilitate TAG synthesis and lipid droplet expansion [134]. Intriguingly, 
DGAT2 also possesses a mitochondrial targeting sequence which recruits mitochondria to lipid 
droplets following treatment with exogenous lipid [133]. This recruitment of mitochondria to 
lipid droplets by a key enzyme in the TAG synthesis pathway supports the involvement of 
mitochondria in lipid droplet expansion [130] (Table 1; Fig. 1). 
PLIN5, a lipid droplet-associated protein, has also been shown to mediate contact with 
mitochondria to promote lipid droplet expansion (Table 1; Fig. 1). PLIN5 overexpression has 
been shown to increase contact between lipid droplets and mitochondria through a 20 amino acid 
sequence on the C terminus of PLIN5 [129,135,136]. However, it is not known if this domain 
interacts with a protein component on the mitochondria, or targets to the mitochondria membrane 
itself. PLIN5-stimulated mitochondria-lipid droplet contact was found to induce lipid droplet 
biogenesis, as both the amount of lipid droplets and incorporation of radiolabeled lipids into 
TAG increased with PLIN5 overexpression [129,135,136]. Conversely, knockout of PLIN5 in 
mice resulted in a loss of lipid droplets and increased β-oxidation [137]. Importantly, although 
PLIN5 has also been shown to negatively regulate lipolysis through inhibitive interaction with 
the lipase ATGL, this effect of PLIN5 overexpression on lipid droplet accumulation and TAG 
production was dependent on the mitochondria interacting domain [129,138]. This indicates that 
the effect of PLIN5 on lipid droplet accumulation is due to its role in mitochondria-lipid droplet 













The outer mitochondrial membrane protein MIGA2 has also been implicated in facilitating lipid 
droplet biogenesis through mitochondria-lipid droplet contact [139] (Table 1; Fig. 1). MIGA2 
overexpression was shown to increase mitochondria-lipid droplet contact following treatment 
with exogenous lipids. This MIGA2-mediated mitochondria-lipid droplet contact was dependent 
on an amphipathic region in MIGA2 that is hypothesized to directly bind the lipid droplet 
membrane. Additionally, MIGA2 was shown to bind to ER–resident VAPs through a FFAT 
motif, suggesting that MIGA2 may also mediate mitochondria-ER contact or a triple-contact site 
between the ER, mitochondria and lipid droplets. MIGA2 knockout adipocytes showed a 
dramatic decrease in lipid droplet accumulation and TAG production during adipocyte 
differentiation, as well as a decrease in the size of remaining lipid droplets. Since lipid droplet 
biogenesis is normally robustly activated during adipocyte differentiation, this suggests MIGA2 
is specifically required for the formation of lipid droplets. However, given the ability of MIGA2 
to facilitate mitochondrial contact with both lipid droplets and the ER, it is not clear from the 
evidence if MIGA2 acts directly on lipid droplet biogenesis through mitochondria-lipid droplet 
contact, or indirectly through mitochondria-ER contact. It would be interesting to assess if either 
the FFAT motif (ER contact), or the lipid droplet binding domain (lipid droplet contact), or both 
are necessary to rescue lipid droplet biogenesis in MIGA2 knockout cells.  
While the role of mitochondria in lipid droplet expansion appears well established, what is still 
unclear is the mechanism by which mitochondria contribute to lipid droplet biogenesis and 
expansion. One theory is that mitochondrial contact functions to provide energy for ATP-
dependent TAG synthesis. This is supported by evidence showing that TAG synthesis is 
sensitive to oligomycin, an inhibitor of ATP synthase, suggesting that TAG synthesis is 
dependent on mitochondrial-derived ATP [129]. Additionally, while lipid droplet-associated 
mitochondria have decreased capacity for β-oxidation under conditions favouring lipid droplet 
expansion, oxidative capacity for non-f tty acid substrates was actually found to be increased 
compared to non-lipid droplet-associated mitochondria [129]. This suggests that mitochondria in 
contact with lipid droplets have elevated ATP production through metabolism of non-lipid fuels.  
An alternative hypothesis is that mitochondria contribute to lipid droplet growth by functioning 
in the synthesis of de novo lipids. In differentiating adipocytes, de novo synthesized lipids were 
shown to be preferentially stored in TAGs over exogenous fatty acids [139]. As the machinery 
involved in de novo lipogenesis involves factors localized to both the ER and mitochondria, it is 
reasonable that the spatial proximity of mitochondria to the ER and lipid droplets may act to 
facilitate synthesis and storage of de novo lipids. Indeed, MIGA2 knockout cells were shown to 
be unable to incorporate glucose derived C
14
 into TAG, which was efficiently performed by WT 
cells [139].  
 
3. Peroxisome-organelle interactions and their physiological relevance 
Peroxisomes are ubiquitous organelles with major functions in cellular lipid and ROS 
metabolism. Peroxisomal lipid metabolism requires cooperation and interaction with the ER, 













by peroxisomal β‐ oxidation involves metabolic cooperation with mitochondria and the ER. The 
synthesis of ether‐ phospholipids (e.g. plasmalogens enriched in myelin sheaths) and 
polyunsaturated fatty acids such as docosahexaenoic acid depends on the metabolic interplay 
between peroxisomes and the ER. Furthermore, peroxisomes are important intracellular signaling 
platforms modulating physiological and pathological processes including innate immunity, 
inflammation, and cell fate decision [141]. 
 
3.1 Peroxisome-ER contacts 
Contacts between peroxisomes and the ER have been known about for some time, since 
peroxisomes were often seen in close association with the ER in early EM images. Indeed, the 
ER is even thought to contribute to de novo biogenesis of peroxisomes. Although the machinery 
behind this process is not completely understood [142], it is suggested that the peroxisomal 
membrane proteins PEX3 and PEX16 may initially be localized in the ER membrane prior to 
their translocation to peroxisomes, through an ER dependent pathway [143]. In mammalian cells, 
peroxisome-ER MCSs are mediated by the ACBD4/5-VAP tether (see 3.1.1) (Table 1; Fig. 2). 
The VAP proteins bind to FFAT-like motifs in ACBD4/5 through their MSP (Major Sperm 
Protein) domain, which facilitates binding to a number of FFAT-containing proteins [144], 
including PTPIP51 (see 2.1.5). The MCSs established between the ER-resident VAP proteins 
and FFAT-containing domain proteins on other organelles are involved in diverse biological 
functions, such as lipid transport, calcium homeostasis, signalling regulation, autophagy, and 
endosome dynamics [145]. Using a proteomic approach, a novel ER-resident protein with a 
FFAT-binding domain, MOSPD2 (Motile Sperm Domain-containing protein 2), was identified 
and characterised. This study showed that MOSPD2 binds FFAT-domain containing proteins 
through the MSP domain, in the same way as the VAP proteins do [145]. While the functions of 
MOSPD2 are not clear and its effect on MCSs is not understood, it is possible that, like VAP 
proteins, MOSPD2 also interacts with ACBD4/5, so may represent a novel peroxisome-ER tether 
[16]. In yeast, the peroxins Pex3, Pex24, Pex32 and the inheritance protein Inp1 have been 
implicated in peroxisome-ER tethering (see 3.1.2) [3,146–148] (Table 1). 
 
3.1.1 Peroxisome-ER contacts facilitate lipid/fatty acid transfer and peroxisome membrane 
dynamics 
In addition to the role of the ER in de novo biogenesis of new peroxisomes, mature peroxisomes 
also require the ER for their function, which is mediated by MCSs between the two organelles. 
The acyl-coenzyme A (CoA)-binding domain proteins ACBD5 and ACBD4 act as tethers to 
mediate peroxisome-ER MCSs, through the binding of their FFAT-like motif to VAP proteins in 
the ER membrane [149–151]. Both proteins belong to the large ACBD family, whose members 
are involved in lipid-binding, cellular signalling, lipid metabolic pathways and controlling 
energy regulation, and are found in eukaryotes and prokaryotes [152]. In addition to their FFAT-
like motifs, peroxisomal ACBD4 and ACBD5 possess an acyl-CoA binding domain at the N-













ACBD5 binds very-long-chain acyl-CoAs and is proposed to facilitate their import into 
peroxisomes for further β-oxidation via the peroxisomal ABC transporter ABCD1. The first 
patients with a loss of ACBD5 function have recently been identified, suffering from retinal 
dystrophy and progressive leukodystrophy; ACBD5 deficiency leads to impaired peroxisomal β-
oxidation of these fatty acids and consequent accumulation [153,154]. Many of the metabolic 
functions of peroxisomes in lipid metabolism are carried out in cooperation with the ER [155]. 
The ER membrane houses enzymes involved in fatty acid elongation (ELOVLs). It is suggested 
that the ACBD5-VAP tether contributes to the formation of a peroxisome-ER metabolic hub that 
allows control of fatty acid chain length (Table 1; Fig. 2). Regulated cooperation at the ER-
peroxisome interface can prevent the synthesis of excess amounts of over-long VLCFA through 
transmission to peroxisomes for degradation via β-oxidation [16]. In support of a peroxisome-ER 
lipid hub, the long-chain acyl-CoA synthetase ACSL1 was recently identified as a direct 
interaction partner of ACBD5 and VAPB [156]. Furthermore, peroxisomes and ER cooperate in 
the synthesis of ether-phospholipids (e.g. myelin sheath lipids), which in mammalian cells is 
initiated in peroxisomes and completed in the ER. Loss of ACBD5 function resulted in a 
reduction in ether-phospholipids [157], supporting the notion that the peroxisome-ER contact 
may facilitate lipid/metabolite transfer for ether-phospholipid synthesis (Table 1; Fig. 2). 
Disruption of peroxisome-ER contacts also prevented peroxisomal membrane expansion, which 
is a pre-requisite for the formation of peroxisomes by membrane growth and division [141,149]. 
Conversely, overexpression of ACBD5 in various mammalian cell lines increased the interaction 
between peroxisomes and the ER and induced peroxisomal membrane expansion in a VAP-
dependent manner [149,151]. These observations support a role of the ACBD5-VAP 
peroxisome-ER contact in peroxisome biogenesis and supply of membrane (phospho)lipids 
(Table 1; Fig. 2). These findings also explain why peroxisomes are hyper-elongated in cells 
from patients suffering from org nelle-division defects. Mutations in the shared 
peroxisome/mitochondria organelle division factors such as DRP1/DNML1 and MFF (see 2.1.1) 
can result in severe disorders with neurological abnormalities and are characterised by defects in 
the membrane dynamics and division of peroxisomes (and mitochondria) rather than by loss of 
metabolic functions [158–161]. The hyper-elongation of peroxisomes in MFF-deficient 
fibroblasts has been suggested to result from a constant ER-peroxisome lipid flow via VAP-
ACBD5 MCSs [149,161,162]. As peroxisomes cannot divide due to the loss of functional MFF, 
lipid supply from the ER causes a pronounced expansion of the peroxisomal membrane. 
Peroxisome membrane expansion can also be achieved by overexpression of MIRO1, a 
mitochondrial Rho GTPase, which also targets peroxisomes [162]. MIRO1 functions as a 
membrane adaptor for microtubule-dependent motor proteins and can exert pulling forces at 
peroxisomes which promote membrane expansion when peroxisomes are tethered. A comparison 
of the peroxisome surface area before and after elongation indicates that the globular peroxisome 
on its own cannot provide sufficient membrane lipids to generate such membrane protrusion; 
these findings further support the hypothesis that membrane lipids are supplied by the ER 
through MCSs [162].  
Disruption of the peroxisome-ER contact in mammalian cells increased the movement of 













mobility and positioning [149,151] (Table 1; Fig. 2). Furthermore, MIRO1‐ mediated pulling 
forces were able to divide and proliferate peroxisomes in fibroblasts due to peroxisome‐ ER 
tethering (which prevented movement of peroxisomes) [162]. In mouse hippocampal primary 
cultures, peroxisomal long range movements were largely diminished and peroxisome number 
reduced following ACBD5 overexpression, coupled with a redistribution of peroxisomes from 
the soma to neurites. However, these alterations were independent of VAPB, which might 
suggest another ACBD5-binding protein contributes to peroxisome-ER contact site formation in 
neuronal cells [163].  
Similar observations have recently been made in the yeast Hansenula polymorpha [146]. This 
study revealed that the peroxins Pex24 and Pex32, which localise to the ER, function as tethers 
to mediate peroxisome-ER contacts (Table 1). Pex24 and Pex32 belong to the Pex23 protein 
family, whose members localise to the ER and contain a dysferlin domain. Deletion of Pex24 or 
Pex32 resulted in a disruption of peroxisome-ER contacts and impaired peroxisome biogenesis, 
proliferation, positioning at the cell cortex and proper segregation to mother cells and buds (see 
3.1.2). These defects were suppressed upon introduction of an artificial peroxisome-ER tether. It 
was also suggested that these proteins may contribute to lipid supply and peroxisomal membrane 
expansion. Interestingly, accumulation of Pex32 at peroxisome-ER contacts was lost in the 
absence of the peroxisomal membrane protein Pex11 (Table 1). Additionally, peroxisome-ER 
contacts were disrupted, indicating that Pex11 functions together with Pex23 family proteins to 
associate peroxisomes to the ER [146]. S. cerevisiae Pex11 is also a component of a peroxisome-
mitochondrion MCS, indicating that Pex11 may contribute to the formation of different MCSs 
[164] (see 3.3). 
 
3.1.2 Peroxisome-ER contacts ensure accurate peroxisome inheritance 
When a eukaryotic cell divides, for example during yeast cell budding, it must partition its 
organelles between the two daughter cells so both are functionally competent. In yeast, the ER-
peroxisome tether is required for peroxisome inheritance during cell division [3]. Knoblach et al. 
showed that in S. cerevisiae, Pex3, a protein required for peroxisome biogenesis, acts as a 
receptor for the inheritance factor Inp1, which is localised at the cortical ER. Recruitment of 
Inp1 to peroxisome-localised Pex3 is required to dock peroxisomes to the cortical ER [147] 
(Table 1; Fig. 2). This immobilization of peroxisomes at the cell cortex ensures the maintenance 
of peroxisome populations and a balanced distribution between mother and daughter cells after 
budding, and may also be involved in the control of peroxisome abundance. Pulling forces 
exerted by the actin-based class V myosin motor Myo2, and constriction forces exerted by the 
peroxisomal division machinery, lead to elongation, constriction and division of the peroxisome. 
The process is asymmetric and leads to the release of larger and smaller peroxisomal fragments, 
which contain the additional factor Inp2, the peroxisomal adaptor for Myo2, and are transported 
to the bud. After its release from Myo2, the bud-localized peroxisome can attach to a tether that 
is recruited by peroxisomal Pex3 binding to Inp1. These studies contributed to the understanding 
of how MCSs influence the mechanistic processes of cell division and organelle segregation, and 














3.1.3 Peroxisome-ER contacts and stress response 
A recent study has demonstrated an interaction between the ER-resident stress sensor ATF6α and 
the peroxisomal fatty acid transporter ABCD3/PMP70, following treatment with the small 
molecule Ceapin. Ceapin selectively blocks the protective activity of ATF6α, excluding it from 
ER exit sites during ER stress, leading to cell death [165,166]. Proteomic analysis identified the 
peroxisomal transmembrane protein ABCD3/PMP70 as a molecular target of Ceapin. It is 
suggested that Ceapin induces interactions between ATF6α and ABCD3, tethering the ER and 
peroxisome and causing ABCD3 to sequester ATF6α from its normal trafficking route without 
interfering with ABCD3‘s normal function (Table 1; Fig. 2). These findings present a step 
towards the understanding of the roles of MCSs in regulating the cellular stress response, as well 
as the therapeutic potential of modulating the proteostasis network [167]. 
 
3.1.4 Peroxisome-ER contacts may facilitate pathogen infection 
Peroxisomes have a crucial role in the cellular defence response to infection [168]. However, 
new studies have suggested that several peroxisomal proteins might also have a role in the 
pathogen replication cycle, which allows the pathogen to spread in the host. One example used 
three-dimensional fluorescence microscopy to reveal that peroxisomes surround the inclusion 
bodies formed by invading Chlamydia, where they are located close to the bacteria. Why 
peroxisomes are necessary for chlamydial infection is still unclear, however peroxisomes may 
shape the cellular lipid content to produce bacteria-specific plasmalogens [169]. It was also 
suggested that peroxisomal plasmalogen synthesis is important for the replication of Zika virus 
(ZIKV) during viral infection, as well as having a crucial role in antiviral defence [170]. Through 
a BioID assay, a set of ER-peroxisome MCS proteins required for lipid transfer (including the 
proteins ABCD3, ACBD5, VAPB and VAPA) were identified as exhibiting high confidence 
interactions with ZIKV proteins [171]. This suggests that viruses may exploit their host lipid 
synthesis, in particular ether lipids, which are synthesised by peroxisome-ER cooperation (see 
3.1.1). The peroxisome-ER contact sites might therefore have a role in the synthesis of virus-
incorporated lipids via transfer of lipid intermediates [149,151] (Table 1). This lipid synthesis is 
crucial for virus replication; indeed, decreased peroxisome-specific ether lipid synthesis impairs 
influenza virus replication [172].  
 
3.2 Peroxisome-lipid droplet contacts 
As key lipid-metabolising organelles, there needs to be extensive cross-talk between 
peroxisomes and lipid droplets to regulate organelle function on both sides. The close 
relationship between peroxisomes and lipid droplets might come from their shared sites of 
biogenesis. A recent study in yeast has shown that the discrete subdomains of Pex30 on the ER 
might be sites for nascent lipid droplet and pre-peroxisomal vesicle (PPV) formation. When there 













PPVs/peroxisomes, which suggests that the Pex30 subdomains might be the site for PPV 
formation [173,174]. The same was also observed for lipid droplets. It was also shown that PPVs 
were associated with lipid droplets at Pex30 subdomains and that the absence of Pex30 causes 
small and clustered PPVs and lipid droplets, which together suggests these two organelles can 
form at the same ER site [175,176].  
Peroxisome-lipid droplet MCSs have been observed in yeast, mammalian and plant cells 
[6,7,177]. In COS-7 cells, ~10% of lipid droplets are in contact with peroxisomes at any one time 
[6]. Since lipid droplets are bounded by a phospholipid monolayer studded with cytosol-exposed 
proteins, tether proteins on juxtaposed organelles could either bind directly to the lipid droplet 
membrane via lipid-interacting domains (for example, the ER resident protein DGAT2, which 
binds the lipid droplet bilayer directly via its C terminal domain), or via protein-protein 
interactions between the apposed membranes [26]. Information about the molecular identities of 
lipid droplet-peroxisome tethers is scarce, with the protein-protein interaction between the lipid 
droplet membrane-bound AAA ATPase M1 Spastin and the peroxisomal fatty acid transporter 
ABCD1 being the best characterised [178] (Table 1; Fig. 2). 
 
3.2.1 Peroxisome-lipid droplet contacts regulate fatty acid trafficking and lipid metabolism 
As peroxisomes are solely responsible for β-oxidation in yeast and plants, neutral lipids stored in 
lipid droplets must be transferred to peroxisomes in the form of free fatty acids for oxidative 
breakdown into acetyl-CoA [179], which requires close coordination between these organelles 
[180]. When yeast cells are grown in oleic acid as the sole carbon source, which is stored in lipid 
droplets after uptake, the number of lipid droplet-peroxisome contacts increases, as the oleate 
must be transferred to peroxisomes to be metabolised by β-oxidation in order to be used to 
generate energy [179]. Conversely, in mammalian cells where both mitochondria and 
peroxisomes cooperate in β-oxidation, excess oleic acid (preferentially oxidised in mitochondria 
in humans) actually reduces the number of lipid droplet-peroxisome contacts, instead increasing 
lipid droplet-lysosome contacts to degrade excess lipid droplets [6].  
Ultrastructural studies in yeast showed that peroxisomes and lipid droplets can interact through 
peroxisomal extensions called pexopodia that extend into lipid droplets. This is proposed to 
proceed via hemifusion between the lipid droplet monolayer membrane and the outer leaflet of 
the peroxisome bilayer membrane – this model would imply direct contact between the inner 
peroxisomal leaflet and the core of the lipid droplet, which would allow the easy diffusion of 
fatty acids across the monolayer [179]. In mammalian cells, on the other hand, a protein-protein 
tether established between the lipid droplet protein M1 Spastin and the peroxisomal fatty acid 
transporter ABCD1 regulates the trafficking of fatty acids between the two organelles (Table 1; 
Fig. 2). Moreover, M1 Spastin recruits ESCRT III proteins to remodel the lipid droplet 
membrane, facilitating fatty acid trafficking at these MCSs [178]. Interestingly, cumyl-OOH 
treatment, which induces lipid peroxidation and consequently oxidative stress, leads to an 
increase in the ABCD1-mediated contacts between lipid droplets and peroxisomes which might 













(Table 1; Fig. 2). Mutations in the gene encoding Spastin (the most common cause of hereditary 
spastic paraplegia) cause aberrant fatty acid metabolism in lipid droplets, along with impaired 
peroxisome movement and distribution and increased lipid peroxidation. This suggests that these 
disorders may be caused by a defect in fatty acid trafficking between lipid droplets and 
peroxisomes. In fact, a mutation in M1 Spastin which failed to induce lipid droplet-peroxisome 
contact formation also impaired fatty acid transport, which corroborates the physiological need 
for a tether between peroxisomes and lipid droplets [3,178].  
Functionally, peroxisome-lipid droplet contacts are also important for efficient lipolysis in 
response to nutrient deprivation. In C. elegans, 12h fasting causes transport of peroxisomes to 
lipid droplets, via the microtubule-dependent motor protein KIFC3, a process which is required 
for effective release of lipids from lipid droplets [181]. Mechanistically, the peroxisomal protein 
PEX5 in mammalian adipocytes (orthologous to the lipolysis-promoting PRX-5 in C. elegans) 
chaperones the translocation of the lipase ATGL from the cytoplasm to the lipid droplets at 
peroxisome-lipid droplet contacts, allowing the liberation of stored triglycerides as metabolic 
substrates during nutrient deprivation, suggesting a role for peroxisome-lipid droplet contacts in 
the utilisation of lipids stored in lipid droplets under a variety of cellular conditions. 
 
3.3 Peroxisome-mitochondria contacts 
Peroxisomes and mitochondria are highly complementary organelles, working in concert to 
execute a number of key cellular functions, such as metabolic processes (including β-oxidation 
of fatty acids), redox/ROS homeostasis and anti-viral signalling [182]. Indeed, peroxisomes and 
mitochondria are so closely connected that the biogenesis of the two organelles involves a 
number of shared proteins, leading to a degree of co-regulation in the number and dynamics of 
these organelles [183]. It is increasingly becoming clear that a physical peroxisome-mitochondria 
connection, at MCSs, can facilitate this well-reported functional peroxisome-mitochondria 
interplay, allowing for coordinated signalling and metabolite exchange between the two 
compartments [16] (Table 1; Fig. 2).  
In yeast, where β-oxidation of fatty acids is carried out solely in peroxisomes, metabolic 
communication between peroxisomes and mitochondria is especially vital for the utilisation of 
fatty acids as an energy source. β-oxidation in yeast generates acetyl-CoAs, which must be 
transferred as membrane-permeable intermediates to mitochondria to be used for ATP 
production by oxidative phosphorylation, while reducing equivalents (malate and 2-oxoglutarate) 
can be shuttled between peroxisomes and mitochondria as one method of regenerating NAD
+ 
in 
the peroxisomes for subsequent rounds of β-oxidation [184–186]. Even in mammals, where both 
peroxisomes and mitochondria house enzymes for β-oxidation, there is a similar need for 
bidirectional peroxisome-mitochondria metabolite transfer. As peroxisomes can only chain-
shorten fatty acids, intermediates are shuttled to mitochondria in the form of acylcarnitine esters 
or free acids to ensure full oxidation [140]. These coordinated metabolic processes also produce 
ROS, contributing to the closely inter-related redox homeostasis and signalling between the two 













The initial observation that around 50% of peroxisomes in yeast cells were found adjacent to 
mitochondria at subdomains of acetyl-CoA synthesis (marked by the presence of pyruvate 
dehydrogenase [PDH]) suggested that close, spatially regulated juxtaposition of the two 
organelles could be important for their interrelated metabolic functions [188]. Both of these 
organelles also form important functional connections with the ER, with peroxisome-
mitochondrial colocalisation often coinciding with ERMES in yeast (see 2.1). The peroxisomal 
membrane protein Pex11 has been shown to interact with the mitochondrial outer membrane 
ERMES component Mdm34 in S. cerevisiae, with the observed decrease in the proportion of 
peroxisomes adjacent to ERMES in Δpex11 cells leading to the proposal that this Pex11-Mdm34 
interaction could act as a peroxisome-mitochondria tether in yeast [164] (Table 1; Fig. 2). 
However, similar to known tethers at other MCSs, peroxisome-mitochondria contacts were not 
completely abolished in Δpex11 cells, suggesting there may be numerous tethering molecules 
between these two organelles. 
Peroxisome-mitochondria contact sites have also been observed in mammalian cells [189], 
though are not as well characterised on a molecular level as those in yeast. Estimates from 
multispectral analysis of 6 tagged organelles imaged simultaneously in live COS-7 cells 
suggested around 20% of peroxisomes are in contact with mitochondria at any one time [6]. 
Interestingly, peroxisome-mitochondria contacts are facilitated by microtubules in these cells, 
since the number of contacts was reduced upon treatment with the microtubule depolymerising 
agent nocodazole (in contrast with peroxisome-ER contacts which were unaffected) [6]. 
Peroxisome-mitochondria contacts seem to preferentially occur at elongated peroxisomal 
membrane protrusions [190], which is reminiscent of the peroxisome tubules that are observed to 
contact mitochondria [191] and lipid droplets [192] in Arabidopsis, though it is currently unclear 
if these represent conventional MCSs or a more dynamic, transient form of organelle 
communication. Juxtaposition of peroxisomes and mitochondria has also been observed in 
neuronal cells [193], but at a much higher frequency than in COS-7 cells (~80% of peroxisomes 
apposed to mitochondria), which may indicate cell type specific differences in the extent of 
MCSs. It is also interesting to consider the high level of peroxisome-mitochondria contact in 
neuronal cells, given the low level of β-oxidation that occurs in the brain, as it suggests that 
mitochondria-peroxisome contacts may function in multiple cellular processes in addition to β-
oxidation. 
 
3.3.1 Peroxisome-mitochondria contacts regulate fatty acid β-oxidation 
Recently, a systematic study investigating all combinations of inter-organelle contact sites has 
further characterised the molecular basis of the peroxisome-mitochondria interaction in yeast. 
Here, split fluorescent proteins fused to the cytoplasmic side of various resident 
peroxisomal/mitochondrial membrane proteins were used to visualise sites where peroxisome 
and mitochondria were close enough for bimolecular fluorescence complementation to occur [7]. 
Importantly, the peroxisome-mitochondria contacts detected by this reporter method localised to 













residing adjacent to ERMES sites and PDH subdomains within mitochondria, suggesting it could 
accurately report on physiological contact sites.  
By using a variety of different lengths of cytoplasmic linker in the reporter fusions, the 
peroxisome-mitochondria contact distance was estimated to be 10-80 nm, consistent with reports 
for other MCSs. To identify candidate tether proteins, a high-throughput overexpression screen 
was performed, highlighting 12 peroxisomal or mitochondrial proteins that, when overexpressed, 
caused an expansion of the peroxisome-mitochondria contact reporter signal [7]. The authors 
focussed on the mitochondrial fusion protein Fzo1 and the peroxisomal membrane protein Pex34 
(a distant Pex11 homologue [7]) as novel tether proteins, demonstrating that both proteins, when 
individually overexpressed, were enriched at MCS and specifically increased the extent of 
peroxisome-mitochondria contacts (Table 1). Interestingly, overexpression of these putative 
tethers also reduced peroxisome motility, which may be a relevant physiological function or 
simply a side-effect of artificially increased organelle tethering. Crucially, this study also 
identified a physiological role for peroxisome-mitochondria tethering in the regulation of fatty 
acid β-oxidation (Table 1; Fig. 2). When yeast were grown on oleate as their sole carbon source 
(conditions in which β-oxidation becomes essential for energy generation), the number of 
peroxisome-mitochondria contact sites detected by fluorescent reporters increased. Concerted 
mitochondria-peroxisome metabolism was assayed by supplementing cells with radiolabeled 
octanoate (C8:0), which in yeast must be metabolised by β-oxidation in peroxisomes to generate 
acetyl-CoA, before being subsequently degraded in mitochondria via the TCA cycle to CO2 and 
H2O. Overexpression of Pex34 led to increased radiolabelled CO2 release, suggesting the 
peroxisome-mitochondria tether facilitates the transfer of acetyl-CoA between the two organelles 
for efficient fatty acid degradation and energy generation. Notably, overexpression of Fzo1 did 
not lead to this increase in β-oxidation, implying it may be part of an independent peroxisome-
mitochondria tether complex with a different, as yet undiscovered, function [7]. 
 
3.3.2 Peroxisome-mitochondria contacts promote steroid biosynthesis 
In testosterone-producing Leydig cells, a molecular ‗tug-of-war‘ between peroxisomes and 
mitochondria, mediated by simultaneous trafficking of the dual-localised acyl-CoA binding 
protein ACBD2 to both of the organelles, has been proposed as a molecular mechanism drawing 
peroxisomes and mitochondria into close proximity [194] (Table 1). Functionally, these 
connections promote steroid biosynthesis in a manner dependent on the acyl-CoA binding ability 
of ACBD2. Moreover, colocalisation of the two organelles is increased upon cAMP stimulation, 
suggesting regulation of these contact sites is important for tightly-controlled, responsive 
metabolism. In agreement with the data obtained in yeast, this supports a physiological role for 
peroxisome-mitochondrial contacts in coordinating the complementary metabolic processes 
between the two organelles, but it remains to be seen whether this involves the direct shuttling of 
key intermediates between the two compartments, which is technically challenging to observe.  
 













Another class of metabolites that could potentially be exchanged at sites of peroxisome-
mitochondria contact are ROS. While both peroxisomes and mitochondria are major producers 
of ROS in the cell, and have therefore historically been assumed to have highly oxidizing 
environments, the luminal environment of the peroxisome has been shown to be reducing in 
comparison to the cytoplasm, potentially due to the high proportion of peroxisome localized 
antioxidants such as catalase [195]. While this reducing capacity likely acts to quench 
peroxisome-derived ROS, evidence suggests that peroxisomes may also function to quench ROS 
from non-peroxisomal sources, including mitochondria.  
In models of peroxisome biogenesis disorders (PBDs), where cells lack functional peroxisomes, 
mitochondria exhibit phenotypes characteristic of mitochondrial oxidative stress including 
structural abnormalities, respiratory chain dysfunction, loss of membrane potential and increased 
expression of the superoxide dismutase SOD2 [196–199]. This mitochondrial dysfunction can be 
rescued by antioxidant treatment, indicating that oxidative stress contributes to mitochondrial 
dysfunction in PBD cells [198]. Additionally, in cells with functional peroxisomes, 
mitochondrial redox homeostasis has been shown to be sensitive to the reducing capacity of 
peroxisomes specifically. Mitochondrial ROS was shown to be elevated when catalase was 
knocked out or chemically inhibited, and restoring targeting of catalase to peroxisomes also 
rescued the loss of mitochondrial membrane potential observed in late-passage cells [200–202]. 
Similarly, compromising peroxisome redox capacity using a peroxisome-targeted photosensitizer 
to overload peroxisomes with peroxisome-generated ROS was shown to increase mitochondrial 
oxidative state [200]. Together, these results indicate that mitochondrial redox homeostasis is 
sensitive to the reducing capacity of peroxisomes and suggest that peroxisomes may function as 
a sink for mitochondria-derived ROS. 
The non-specificity and high reactivity of ROS means that they are short lived species, unable to 
travel long distances. To avoid oxidative damage by reaction with non-intended proteins and 
lipids, ROS production is spatially linked to reducing components. If peroxisomes are one of 
these reducing components, it stands to reason that they would need to be in spatial proximity of 
mitochondria, such as the close proximity provided by MCSs, to receive mitochondrial ROS 
within the lifetime of the ROS. While exchange of ROS at sites of peroxisome-mitochondria 
membrane contact has yet t  be shown, ROS exchange has been shown to occur at contact sites 
between the ER and mitochondria, indicating ROS exchange at MCSs is feasible [203]. 
 
3.4 Peroxisome-lysosome/vacuole/endosome contacts 
Similarly to mitochondria, the most obvious contact between peroxisomes and 
lysosomes/vacuoles occurs during the degradation of damaged or unwanted peroxisomes and 
subsequent recycling of organelle components. The interplay between peroxisomes and 
autophagosomes has recently been reviewed [204]. However, novel physiological functions of 
MCSs, independent of degradation, have been elucidated. Although numerous proteins have 
been implicated in the formation/regulation of peroxisome-lysosome contacts [205,206], few 
have been directly shown to have a tethering function. The distinct protein and membrane 













specificity via restricted tether formation, exemplified by the sole characterised lysosomal-
peroxisomal tether formed by the lysosomal membrane protein Syt7 binding to PI(4,5)P2, which 
is enriched in the peroxisomal membrane, via its C2AB domain [206] (Table 1; Fig. 2). 
 
3.4.1 Peroxisome-lysosome contacts mediate cholesterol transport and VLCFA metabolism 
In mammalian cells, as previously discussed (see 2.2.2), cholesterol is primarily taken up from 
the external environment by endocytosis in the form of low-density lipoprotein (LDL). This is 
subsequently trafficked via the endocytic pathway to lysosomes for processing, before being 
distributed to downstream compartments, including the plasma membrane, where it contributes 
to membrane structure, metabolism and intracellular signalling [207].  
The importance of peroxisomes in intracellular cholesterol trafficking was first identified via an 
unbiased RNAi screen for proteins regulating cholesterol transport out of lysosomes, as the pool 
of candidate knockdown genes causing a defective cholesterol trafficking phenotype was 
significantly enriched in peroxisomal genes [206]. Peroxisomal and lysosomal markers 
colocalised at dynamic and transient contact sites between the organelles, which were reduced if 
key peroxisome, lysosome or cholesterol trafficking proteins were depleted. Peroxisome-
lysosome contacts are at least in part bridged by the lysosomal protein Syt7 binding to PI(4,5)P2 
in the peroxisomal membrane, with both components being required for the transport of 
cholesterol from lysosomes to peroxisomes (Table 1; Fig. 2). Importantly, the extent of these 
peroxisome-lysosome contacts was reversibly reduced following cholesterol depletion, 
indicating physiological regulation by cellular cholesterol status. Peroxisome-ER contacts have 
also been implicated in the trafficking of cholesterol out of the lysosome [208], suggesting a 
novel, non-vesicular mechanism by which peroxisomes facilitate the transport of LDL-derived 
cholesterol from the lysosome to the ER by direct contacts with both organelles, perhaps even 
acting as a transient carrier to buffer cellular cholesterol levels and/or shuttle it to downstream 
compartments as required. 
Highlighting the importance and clinical relevance of peroxisomes and peroxisome-lysosome 
contacts in normal cholesterol distribution, patients with peroxisomal disorders display 
intracellular cholesterol accumulation resembling patients with direct cholesterol transport 
disorders. Defects in intracellular cholesterol distribution perturb normal cell and membrane 
function, for example a recent study has associated a reduction in peroxisome-lysosome 
mediated cholesterol transport with impaired ciliogenesis [205]. Maharjan et al. identified 
TMEM135 (PMP52) as a novel peroxisomal protein regulating peroxisome-lysosome contacts. 
Knockdown of TMEM135 in mammalian cells decreased peroxisome-lysosome colocalization 
(without changing organelle numbers) and increased cholesterol accumulation in the lysosome, 
suggesting these TMEM135-mediated contacts are required for transport of internalised 
cholesterol from the lysosome to peroxisomes (Table 1). Interestingly, TMEM135 depletion also 
impaired cilia formation by reducing trafficking of the ciliary vesical GTPase Rab8 to centrioles, 
which could be rescued by cholesterol supplementation [205]. Together, this suggests a model by 













physiological distribution of intracellular cholesterol, which in turn is essential for ciliogenesis. 
Additionally, peroxisomal dysfunction caused by Schwann cell-specific PEX5 knockout leads to 
secondary lysosomal storage disorder-like phenotypes and subsequent peripheral neuropathy in 
mice, due to an accumulation of gangliosides as lysosome-generated VLCFAs cannot be 
degraded in peroxisomes [209]. Altogether, this suggests a role for peroxisome-lysosome 
contacts in cholesterol transport and VLCFA homeostasis.  
 
3.4.2 Peroxisome-vacuole/endosome contacts promote peroxisome expansion and 
distribution 
Recently, a novel peroxisome-vacuole contact site has been described in the yeast H. 
polymorpha [210], distinct from the transient contact preceding fusion of the two organelles 
leading to peroxisome degradation (micropexophagy) [211]. Several systematic studies have also 
detected this contact in S. cerevisiae using split fluorescent protein reporters [7,212]. Notably, in 
H. polymorpha, no peroxisome-vacuole contacts were detected by EM when the cells were 
grown on glucose-containing media, which represses pe oxisome growth (cells in these 
conditions typically only possess one small peroxisome), however, upon switching to methanol-
containing media, which promotes rapid peroxisome expansion and development, these MCS 
could be observed [213]. These peroxisome-vacuole contacts were dependent on the peroxisomal 
membrane protein Pex3, which accumulated at the peroxisome-vacuole interface upon induction 
of peroxisome growth, and was sufficient to form peroxisome-vacuole MCS under peroxisome-
repressive conditions when overexpressed, though the molecular mechanism underlying this 
remains to be elucidated (Table 1). The presence of peroxisome-vacuole contacts exclusively 
under peroxisome growth conditions raises the possibility that the vacuole could be acting to 
provide a source of lipids to fuel the rapid expansion of the peroxisome membrane, similar to the 
lipid transfer that occurs at peroxisome-ER MCS [149] (see 3.1.1), however, this has yet to be 
proven.  
MCSs are also crucial for the transport and positioning of many organelles [3]. For example, in 
filamentous fungi peroxisomes hitchhike on endosomes for long-range movement along 
microtubules, via the interaction of peroxisomes with the endosome-associated protein PxdA, 
generating MCSs that allow the peroxisomes to hitch a ride on endosomes as they are moved by 
the microtubule-based motors dynein 1 and kinesins [214,215] (Table 1).  
 
4 Golgi-organelle interactions and their physiological relevance 
As a major trafficking and protein-sorting hub of the cell, the Golgi complex needs to 
communicate with a range of organelles to ensure processed cargo is directed to its correct 
destination [216]. Systematic analysis of the whole-cell organelle interactome in mammalian 
COS-7 cells has revealed that the Golgi makes a relatively small number of contacts with the ER, 
mitochondria, peroxisomes, lysosomes and lipid droplets [6], and the Golgi also forms three-way 













However, only Golgi-ER MCSs have been characterised on the molecular and functional level 
[20] (Table 1; Fig. 3). 
 
4.1 Golgi-ER contacts 
There is extensive bidirectional communication between the Golgi and the ER, due to their 
shared function ensuring accurate biosynthesis and distribution of essential intracellular and 
secreted components. Newly synthesised proteins and lipids are trafficked from the ER to the cis 
face of the Golgi for further processing and sorting, before being released to their final 
destination from the trans-Golgi network (TGN) [216]. While vesicle-mediated transport of these 
proteins and lipids between the Golgi and the ER is well characterised, it is becoming 
increasingly clear that non-vesicular transfer via MCSs also plays a key role [20] – indeed, non-
vesicular transport of ceramide can compensate when vesicular trafficking pathways are blocked 
in both yeast and mammalian cells [218,219]. Consequently, several of the identified ER-Golgi 
tether proteins also possess lipid transfer functions to facilitate this [20] (Table 1; Fig. 3). So far, 
no integral Golgi proteins have been identified as ER-TGN tethers, however all known 
cytoplasmic tether components contain PH domains that preferentially bind the phosphoinositide 
PI(4)P, which is enriched at the TGN membrane [220]. The nature and functions of ER-Golgi 
MCSs are likely to vary between different organisms, due to large variations in the structure and 
arrangement of the Golgi across eukaryotes [221]. ER-Golgi MCSs have been extensively 
reviewed (see [20,216,221,222]), but some of the identified physiological functions will be 
briefly discussed here. 
 
4.1.1 Golgi-ER contacts facilitate lipid transfer 
As previously discussed (see 2.1.3), the ER is the major biosynthetic hub for lipids in the cell, 
some of which need to be subsequently transported to the Golgi for incorporation into the Golgi 
membrane, distribution around the cell or further processing by Golgi-resident enzymes [222]. In 
mammals, several members of the oxysterol-binding protein/OSBP-related protein family 
(ORPs) have been proposed as components of ER-TGN tether complexes that facilitate direct 
transport of sterols between the two apposing membranes, bypassing earlier secretory 
compartments [20] (Table 1; Fig. 3) Eight of the twelve human ORP proteins, and three of the 
seven homologous Osh proteins in S. cerevisiae, possess FFAT motifs, allowing them to interact 
with VAP proteins (or their yeast homologues Scs2/Scs22) in the ER membrane at MCSs in a 
manner inversely proportion to their sterol-binding function [223]. Of these, two – OSPB1 and 
ORP9 – have been shown by FRET-FLIM to be important as redundant VAP-binding tethers for 
the formation of ER-TGN contacts, and while ORP10 appears to be important for the 
maintenance of these contacts, it is unclear whether this is a bona fide tether as it only possesses 
a putative FFAT motif [220].  
Mechanistically, ORP9 localises to the TGN via a PI(4)P-preferring PH domain, and can 













cholesterol accumulation in the endosomal/lysosomal compartment, suggesting ORP9 acts to 
transfer endocytosed cholesterol between the ER and TGN under normal conditions, which when 
blocked overwhelms the lysosomal trafficking pathway instead. Interestingly, ORP9 knockdown 
also causes Golgi fragmentation, suggesting a role for ER-TGN MCSs and/or normal cholesterol 
flux in Golgi integrity [224]. OSBP1 forms ER-TGN tethers by a similar mechanism, 
simultaneously binding PI(4)P and VAPA on separate membranes in vitro and promoting PH- 
and FFAT-dependent ER-TGN tethering in vivo [225]. Overexpression of WT OSBP1, but not a 
FFAT mutant, resulted in a reduction in lipid droplet formation from exogenous cholesterol, 
whereas knockdown or inhibition of OSBP1 led to decreased cholesterol in the TGN but 
increased cholesterol in lipid droplets [226]. Since lipid droplets form from the ER, this suggests 
OSBP1 counteracts the retrograde flux of cholesterol into the ER by driving ER to TGN 
cholesterol transport at ER-TGN MCSs [225]. Altogether, this indicates that ORP9 and OSBP1 
not only function as physical tethers at ER-TGN MCSs, but also function to transport cholesterol 
between the two membranes to maintain normal cholesterol flux. 
In mammals, ceramide is another lipid that must be transported between the ER and the Golgi, as 
it is synthesised in the ER but can only be converted to sphingomyelin, which is a crucial 
component of axonal myelin sheaths, in the Golgi [219]. The PI(4)P-binding protein CERT was 
initially identified as the essential Golgi-associated factor mediating the ATP-dependent, non-
vesicular ER to Golgi ceramide translocation, and was shown to be able to drive intermembrane 
ceramide transfer in vitro via a ceramide-binding domain [219]. It was subsequently 
demonstrated that CERT binds the VAP proteins via its FFAT motif, with its ER-TGN tether 
function being required for ceramide transfer in cells [227], providing another example of lipid-
binding proteins that simultaneously bring the ER and Golgi membranes into close apposition as 
MCS tethers, whilst also carrying out a lipid transfer function. 
 
4.1.2 Golgi-ER contacts regulate phosphoinositide distribution and homeostasis 
The phosphoinositide composition of the Golgi membrane is highly regulated, with localised 
enrichment of PI(4)P at the TGN being crucial for the concentration and spatial sorting of certain 
lipid and protein cargoes [20]. PI(4)P turnover is regulated by ER-TGN MCSs via several 
mechanisms. Interestingly, the ER to TGN cholesterol transport mediated by OSBP is 
energetically driven by PI(4)P transfer in the opposite direction. The same lipid transfer domain 
in OSBP1 can transfer either PI(4)P or cholesterol between membranes in vitro, as long as its 
tether function is also intact, implying a cycle whereby OSBP1 alternately exchanges cholesterol 
and PI(4)P between the ER and TGN membranes at ER-TGN MCSs [225] (Table 1; Fig. 3). 
Once at the ER membrane, PI(4)P can be hydrolysed to PI by the ER-resident phosphatase Sac1 
[225], while PI(4)P is regenerated at the TGN by PI(4)-kinases such as PI4KIIIβ, which is 
recruited to the TGN membrane by the Golgi protein ACBD3 [152,228]. Coupled together, this 
maintains the PI(4)P concentration gradient between the TGN and ER, both ensuring the 
directionality of cholesterol transport and establishing the difference in membrane composition 
that is required for downstream signalling and function [226]. Importantly, since ER-Golgi 













TGN versus its synthesis may represent a mechanism by which the extent of ER-Golgi tethering 
may be regulated [222].  
While this cholesterol/PI(4)P exchange model suggests that ER-localised Sac1 acts to 
dephosphorylate PI(4)P after it has been transferred to the ER membrane (in cis), an alternative 
hypothesis has proposed that Sac1 can also act directly on PI(4)P in the TGN membrane across 
the ER-TGN MCS (in trans). This is based on evidence that destabilising ER-TGN MCSs, for 
example by VAP knock-down, results in PI(4)P accumulation at the Golgi, assuming that closer 
membrane contacts are required for Sac1 activity in trans as opposed to OSBP1-dependent Sac1 
activity in cis [229]. Phosphatidyl-four-phosphate-adaptor-protein-1 (FAPP1) was identified as a 
regulator of this Sac1 trans activity, as its knockdown resulted in TGN accumulation of PI(4)P 
without disrupting ER-TGN MCSs [229]. FAPP1 binds PI(4)P and localises to ER-TGN MCSs, 
forming a tripartite complex by binding the VAP proteins and Sac1. In vitro liposome studies 
showed that FAPP1 has a strong stimulatory effect on Sac1 dephosphorylation of PI(4)P in trans, 
but a far smaller effect in cis, implying FAPP1 acts as an adaptor at closely-associated ER-TGN 
MCSs to reduce PI(4)P levels in the TGN via direct Sac1 activity across the MCS [229]. 
Functionally, FAPP1- and Sac1-dependent reduction of PI(4)P at the TGN decreases secretion of 
certain cargoes from the TGN, suggesting regulation of PI(4)P turnover by modulating ER-TGN 
MCS complexes fine-tunes protein trafficking through the secretory system [229]. Together, 
these non-exclusive models raise the possibility that ER-TGN MCSs with different compositions 
may influence PI(4)P homeostasis in independent ways, perhaps depending on cellular context. 
 
5 Plasma membrane-organelle interactions and their physiological relevance 
As well as acting as a physical boundary around the cell, the plasma membrane (PM) plays a 
number of key roles in cellular physiology, including transport/trafficking of ions and molecules 
between the inside and outside of the cell, relay of extracellular signals and control of 
morphology/polarity. As a result, the PM must act in concert with other cellular components, so 
accordingly forms MCSs with numerous organelles (Fig. 3). Interactions between PM-ER and 
PM-mitochondria are the best characterised [21,230]; novel MCSs between the PM and 
vacuoles, lipid droplets and peroxisomes have recently been observed but the molecular 
composition and physiological function of these contacts is currently unknown [7,231]. 
 
5.1 Plasma membrane-ER contacts 
In yeast, ER-PM contacts are frequently observed due to the extensive network of cortical ER at 
the cell periphery in these cells – in fact, split fluorescent reporters have been used to 
demonstrate that virtually all of the cortical ER is within 20 nm of the PM and therefore 
comfortably within the range of MCS formation [232]. Interestingly, several of the reported ER-
PM tether proteins are homologues of the mammalian VAP family of proteins, which are 













(Table 1). Since these VAP proteins may participate in a number of MCS complexes 
simultaneously, how they are regulated independently is an important outstanding question. 
 
5.1.1 Plasma membrane-ER contacts regulate sterol transport 
As the ER is a major site of lipid biosynthesis in the cell, a key role of ER-PM contact sites is to 
carry out the regulated non-vesicular transport of essential lipids from their site of biogenesis to 
the PM, where they contribute to membrane integrity and function. In particular, oxysterol-
binding protein–related proteins (e.g. the Osh family in yeast), have been implicated in the 
transport of sterols from the ER to the PM [233]. In S. cerevisiae, 4 members of the Osh family 
of proteins (Osh2,3,6 and 7) are observed to be localised to ER patches adjacent to the PM – 
interestingly, while Osh2 and Osh3 contain a FFAT motif predicted to bind ER resident VAP 
proteins, this does not appear to be essential for this localisation since Osh6 and Osh7 do not 
possess such a motif [234] (Table 1; Fig. 3). The Osh proteins have multiple membrane binding 
surfaces, allowing them to simultaneously bind to both the ER and the PM in vivo. Elegant in 
vitro experiments studying Osh-mediated sterol transport between liposomes, where the donor 
and acceptor liposomes were either in close proximity or separated with a semipermeable barrier, 
demonstrated that the two membranes need to be closely apposed for Osh-induced sterol transfer 
to occur. Together, this suggests a model whereby the Osh proteins physically bridge the ER and 
PM, to bring them into close enough proximity for sterol transfer between the two membranes to 
be facilitated [234]. 
Structural reorganisation of the PM provides a novel mechanism for the regulation of PM-ER 
contacts. In S. pombe, PM invaginations mediated by large immobile protein complexes known 
as eisosomes help to stabilise local PM-ER contacts [235]. Interestingly, these seem to be able to 
directly restrict cortical ER remodelling to modulate PM-ER contacts, allowing a degree of 
plasticity to regulate cortical processes depending on cellular demands. Close apposition of 
cortical ER and morphologically similar PM furrows (caveolae) has also been observed in 
animal cells [236], raising the possibility that this may represent a conserved mechanism by 
which PM-ER cross-talk is regulated.  
 
5.1.2 Plasma membrane-ER contacts regulate phosphoinositide metabolism 
Osh-mediated tethering of the ER and PM has been proposed to regulate another important 
function of the PM, phosphoinositide metabolism, which is important for a range of signalling 
pathways. In yeast cells lacking the Osh proteins, the ER displays a more perinuclear 
distribution, and the PM contains significantly more PI(4)P [237], modulating PM charge and, 
consequently changing its electrostatic protein binding properties [238]. Mechanistically, the Osh 
proteins regulate PM PI(4)P homeostasis by activating the ER-resident PI(4)P phosphatase Sac1 
at ER-PM contacts as part of a MCS complex including the VAP homologues Scs2 and Scs22. 
However, deletion of Scs2 and Scs22 causes a smaller increase in PM PI(4)P levels than deletion 













possible additional tether candidates, proteins that bound to both Sac1 and Scs2 were identified 
by SILAC [239]. Of these, Ist2 and the tricalbin (Tcb) family of proteins also localised to the 
cortical ER, suggesting they may take part in the ER-PM MCS complex (Table 1; Fig. 3). 
Supporting this, strains lacking Scs2/22, Ist2 and Tcb1/2/3 showed a drastic reduction in cortical 
ER, which was instead collapsed in the cytosol, as well as increased PI(4)P in the PM. 
Interestingly, these cells, in which PM-ER contacts are disrupted, constitutively activated their 
unfolded protein response (UPR), indicative of ER stress, suggesting that ER-PM contacts are 
also required for some uncharacterised aspect of normal ER function. Mammalian proteins at 
MCSs involved in phosphatidylinositol delivery between the ER and the PM include NIR2 and 
C2CD2L/TMEM24 [240,241]. 
 
5.1.3 Plasma membrane-ER contacts in Ca
2+ 
homeostasis and autophagy 
In mammalian cells, it has been demonstrated that ER-PM contacts play an important role in 
refilling the ER Ca
2+





 sensor STIM1 redistributes to clusters closely apposed to the PM (within 
10-25 nm) following cellular Ca
2+
 depletion with EGTA [243], via a direct interaction with the 
PM store-operated Ca
2+ 
channel Orai1, which it activates [244]. Thus, similarly to mitochondria-
PM contacts (see 5.2), this ER-PM contact acts to specifically and spatially target Ca
2+
 entry to 
the required location for repletion of ER Ca
2+ 
stores to efficiently maintain cellular Ca
2+ 
homeostasis (Table 1; Fig. 3). Recent evidence in plants has also implicated ER-PM contacts in 
facilitating autophagy, with autophagosome formation being initiated at the interface between the 
ER, PM and F-actin [245]. The continuous discovery of new functions, such as these, mediated 
by organelle-PM contacts shows the importance and versatility of these MCSs, which will likely 
be a burgeoning area of research in the future. 
 
5.2 Plasma membrane-mitochondria contacts 
While the mechanics of mitochondria-PM contacts have not been determined in mammalian 
cells, this contact has been well characterized in yeast. The core component in mitochondria-PM 
contact sites in yeast is Num1, a cortical protein shown to interact with dynein as well as 
mitochondria fission machinery [246,247]. Num1 directly binds PI(4,5)P2 in the PM through a 
PH domain, as well as cardiolipin in the mitochondria membrane through a coiled coil domain, 
thereby bridging mitochondria and the PM [248–251] (Table 1; Fig. 3). Num1 also self-
associates through the coiled coil domain into clusters which are required for Num1‘s tethering 
capacity [248,250]. Mdm36, a soluble protein peripherally recruited to the mitochondria 
membrane, is also recruited to Num1-mediated mitochondria-PM contact sites through a coiled 
coil-mediated interaction with Num1, and is proposed to facilitate oligomerization of Num1 into 
functional clusters [248,250]. The ER also localizes to sites of mitochondria-PM contact. ER 
proteins are found to co-purify with Num1 and the ER is shown to be present in all cases of 
mitochondria-PM contact [248]. Num1 has been shown to interact with the ER resident 













to defective Num1 distribution [252,253]. This three-way mitochondria-PM-ER contact site is 
termed the mitochondria-ER cortex anchor (MECA). 
 
5.2.1 Plasma membrane-mitochondria contacts function in mitochondrial inheritance 
Mitochondrial distribution within the cell has profound consequences for the inheritance of these 
organelles. Contact between mitochondria and the PM has been shown to facilitate correct 
partitioning of mitochondria between mother and daughter cells in S. cerevisiae. During budding, 
mitochondria are anchored to the bud tip as well as the mother cell cortex and are partitioned 
evenly in both directions by bi-directional actin-dependent movement [254]. Num1 localized to 
the mother cell cortex acts to retain mitochondria in the mother cell by mediating PM-
mitochondria contact. Loss of Num1 leads to asymmetric mitochondria distribution shifted 
towards the bud [247–249]. Other mitochondrial tether proteins involved in inheritance are 
Mmr1 and Mfb1 [255,256]. Similarly, in mammalian mammary cells, PM-mitochondria contacts 
are important to mediate the asymmetrical distribution of mitochondria required for the 
epithelial-mesenchymal transition (EMT) during development [257] (Table 1). The inheritance 
of more mitochondria in a daughter cell is associated with increased mitochondrial fusion, a 
decrease in ROS and thus a more stem cell-like phenotype, driving EMT. Mechanistically, this 
asymmetrical distribution requires PM-mitochondria contacts, which are increased in response to 
EMT-inducing TGFβ1 signalling and potentially mediated by an interaction between the 
mitochondrial fusion protein MFN1 and the kinase PKCζ at the PM. Mitochondria are also 
recruited to the cleavage furrow during mammalian cytokinesis, although it is not known if 
interactions with the PM participate in this recruitment [258].  
 
5.2.2 Plasma membrane-mitochondria contacts function in Ca
2+
 influx 
In mammalian cells, mitochondria-PM contact is suggested to function in regulating Ca
2+
 influx, 
specifically in relation to intracellular communications such as synaptic signalling and T cell 
activation [259–261]. In response to depletion of intracellular Ca
2+
 stores, primarily from the ER, 
the cell stimulates an influx of extracellular Ca
2+
 through calcium transporters at the plasma 
membrane, such as the calcium release-activated channel (CRAC), to restore ER Ca
2+
 stores 
[262]. As CRAC activity is negatively regulated by Ca
2+
, newly imported Ca
2+
 must be 
sequestered away from CRAC to prevent negative feedback and allow for sustained Ca
2+
 influx 
[263,264]. Uptake of Ca
2+
 by subplasmalemmal mitochondria has been shown to function in 
sequestering Ca
2+
 that enters the cell through CRAC to promote CRAC activation. Ca
2+
 influx 
following depletion of ER Ca
2+
 is temporally correlated with movement of mitochondria to the 
PM. This mitochondrial movement is dependent on extracellular Ca
2+
 and CRAC activity, 
indicating that mitochondria movement is a response to Ca
2+
 import specifically [265]. As well, 
influx of extracellular Ca
2+
 imported through CRAC is correlated with increased mitochondrial 
Ca
2+
 levels, indicating that influxed Ca
2+
 is shuttled into mitochondria [266]. Together this data 
indicates that import of Ca
2+
 into mitochondria is required for Ca
2+
 influx by preventing 
accumulation of Ca
2+













The mitochondrial calcium uniporter has a very low affinity for Ca
2+
 and can only be activated 
by high (μM) concentrations of Ca
2+
, far exceeding physiological concentrations [267]. It is 
proposed that this high concentration is achieved through proximity of the mitochondrial calcium 
uniporter to source calcium channels at MCSs, where microdomains of high Ca
2+
 are formed. 
This type of spatial coupling between calcium source channels and the mitochondria calcium 
uniporter at contact sites has been extensively studied at the mitochondria-ER contact site [54]. 
Thus, the regulation of local Ca
2+
 concentrations immediately proximal to CRAC channels by 
mitochondria necessitates tight proximity of mitochondria to CRAC channels, such as would be 
achieved by mitochondria-PM contact. In support of this, mitochondria Ca
2+
 uptake was shown 
to increase with increasing Ca
2+
 influx, even under conditions where global cellular Ca
2+
 content 
was kept constant. This suggests that mitochondria specifically respond to local Ca
2+
 levels in 
the proximity of CRAC channels, and that mitochondria are close enough to such channels to do 
so [266]. Additionally, a number of studies which spatially examined mitochondrial Ca
2+
 uptake 
correlated mitochondria proximity to the PM with mitochondrial Ca
2+
 import [268–270].  
 
6 Conclusions/perspectives 
After a period of describing MCSs between different organelles and the tethers involved, the 
field is now moving towards unraveling the diverse functions of organelle contacts and their 
physiological importance. As evident from the above (see also Table 1), generic physiological 
functions of MCSs include roles in membrane lipid exchange, channeling of metabolites, ion 
homeostasis and signalling, as well as organelle biogenesis and dynamics, including organelle 
positioning, transport and inheritance.  
Although the mechanisms of lipid exchange at MCSs are not well understood, it is suggested that 
lipid transfer facilitates channeling of lipids to specific compartments to support metabolic 
processes as well as the membrane expansion of organelles such as mitochondria and 
peroxisomes (see 2.1.3, 2.3.2, 3.1.1, 3.4.2). Lipid transfer may also change the membrane lipid 
composition (e.g. to allow membrane remodeling for deformation and expansion) and modulate 
signalling processes at membranes (e.g. through phosphatidylinositols) (see 2.1.3, 4.1.2, 5.1.2). 
In addition, it has been proposed that non-vesicular lipid transfer through MCSs can compensate 
for an impairment of vesicular transport [271], thus linking MCSs to vesicular trafficking. In line 
with this, MCS also play a role in protein sorting in endosomal trafficking pathways [272].  
Metabolic channeling at MCS allows efficient transfer of metabolites between compartments. 
MCSs may help to concentrate substrates at the organelle interface and control substrate 
activation (e.g. synthesis of fatty acyl-CoA) and entry into organelle-specific pathways (e.g. fatty 
acid β-oxidation versus fatty acid elongation at the peroxisome-ER interface) (see 3.1.1). This 
may prevent the consumption of those metabolites by other pathways, as well as their 
accumulation, which may have toxic effects for the cell. Metabolites that are channeled include 
fatty acids, ceramides and sterols but also iron and calcium (see Table 1). ER-mitochondria 
MCSs determine mitochondrial Ca
2+
 levels thus controlling mitochondrial functions (e.g. 













MCSs also play important roles in cellular signalling. They facilitate the exchange of signalling 
molecules such as Ca
2+
, ROS and signalling lipids (e.g. phosphoinositides) (see 2.1.2, 5.1.3, 
5.2.2, 2.1.4, 4.1.2, 5.1.2), often across several compartments. In this respect, the understanding of 
MCSs between multiple organelles is of interest (e.g. triple contacts). MCSs also serve as 
signalling hubs by assembling proteins involved in signal transduction, which has been linked to 
cellular stress responses (e.g. oxidative stress, lipid peroxidation, starvation). These conditions 
can trigger apoptosis and may link MCSs to age-related diseases such as neurodegeneration, 
cancer and Type 2 diabetes. How MCSs are altered under certain cellular stress conditions and 
how they may help to overcome cellular stress is of major interest in the field. Future studies will 
reveal what important roles MCSs may play in age-related and metabolic disorders. 
Finally, MCSs regulate organelle membrane dynamics. As previously mentioned, lipid transfer 
allows membrane expansion and shape changes of the organelles, which are often linked to 
organelle biogenesis (e.g. membrane growth prior to organelle multiplication) (see 3.1.1, 3.4.2). 
MCS also determine sites of organelle fission, often in conjunction with the ER and actin 
assembly providing mechanical roles. MCSs can anchor organelles at specific cellular locations 
thereby regulating organelle transport, positioning and inheritance (see 3.1.2, 5.2.1). They are 
also involved in autophagosome formation determining organelle number and quality control. 
There are still many unknowns surrounding the physiological functions, properties and 
regulatory mechanisms of MCSs, though our understanding is rapidly increasing. For example, 
an intriguing recent study has made the novel suggestion that phase properties of the ER 
membrane may influence the types of contact sites it makes. Using large intracellular vesicles 
isolated from hypotonic cell swelling and labelled to determine organelle identity, King et al. 
demonstrated that contacts with PM, mitochondria and endosomes occur at ER membrane 
subdomains characterised by ordered lipids, whereas lysosomes and peroxisomes form contacts 
at disordered ER membrane subdomains [273]. While the mechanism behind this remains 
unclear, it may represent an additional level of spatial and/or functional regulation of ER-
organelle contact sites within the crowded cellular environment. Since MCSs are evidently vital 
for a whole host of physiological functions, the various levels and mechanisms by which they are 
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Table 1. Organelle interaction, MCS components and physiological role. ABCD1/3, ATP-
binding cassette sub-family D member 1/3; ACBD2/4/5, acyl-coenzyme binding domain protein 
2/4/5; ACSL1, long chain fatty-acid-CoA ligase 1; AMPK, 5‘ AMP-activated protein kinase; 
ATF6α, activating transcription factor 6α; DGAT2, diacylglycerol O-acyltransferase 2; DMT1, 
divalent metal transporter 1; ENDO, endosome; ER, endoplasmic reticulum; ERMES, ER-
mitochondria encounter structure; FAPP1, phosphatidyl-four-phosphate-adaptor-protein-1; 
FATP1, fatty acid transporter protein 1; GRP75, glucose regulated protein 75; INF2, inverted 
formin 2; IP3R, 1,4,5-trisphosphate receptor; LD, lipid droplet; LYS, lysosome; MAVS, 
mitochondrial anti-viral signalling protein; MIGA2, mitoguardin 2 protein; MITO, mitochondria; 
NLRP3, nucleotide-binding oligomerization domain-like receptor 3; OSBP1/ORP5/8/9/10/11, 
oxysterol-binding protein/OSBP-related protein family; PEX, peroxin; PI(4,5)P2, 
phosphatidylinositol-4,5-bisphosphate; PLIN5, perilipin 5 protein; PM, plasma membrane; PO, 
peroxisome; STARD3, StAR related lipid transfer domain containing protein 3; STIM1, stromal 
interaction molecule 1; TBC1D15, TBC1 domain family member 15; TMEM135, 
transmembrane protein 135; VAP, vesicle-associated membrane protein; VDAC, voltage 
dependent anion channel; VPS13, vacuole protein sorting-associated protein 13. MCS proteins 
are mammalian unless otherwise stated. * MCS components listed are those mentioned in the 
text; this is not a complete list of all MCS components identified so far.  
Figure 1. Schematic overview of mitochondrion-organelle interactions and their 
physiological relevance. DGAT2, Diacylglycerol O-acyltransferase 2; ER, Endoplasmic 
Reticulum GRP75, Glucose-Regulated Protein 75; IPR3, 1,4,5 – triphosphate receptor; LD, Lipid 
Droplet; LYS, Lysosome; MAVS, Mitochondrial Antiviral-signalling protein; MIGA2, 
Mitoguardin 2 protein; MITO, Mitochondrion; NLRP3, Nucleotide-binding oligomerization 
domain-like receptor protein 3; PLIN5, Perilipin-5 protein; PTPIP51, Protein Tyrosine 
Phosphatase Interacting Protein 51; STARD3, Star-related lipid transfer protein 3; VAPB, 
Vesicle-Associated Membrane Protein (VAMP)-associated Protein B; VDAC, Voltage-
Dependent Anion-selective Channel; VPS13A, Vacuole Protein Sorting-associated protein 13 
isoform A. 
Figure 2. Schematic overview of peroxisome-organelle interactions and their physiological 
relevance. ABCD, ATP Binding Cassette subfamily D member; ACBD, Acyl-CoA Binding 
Domain containing protein; ATF6α, Activating Transcription Factor 6α; ER, Endoplasmic 
Reticulum; Inp1, Inheritance of peroxisomes protein 1; LD, Lipid Droplet; LYS, Lysosome; 
Mdm34, Mitochondrial distribution and morphology protein 34; MITO, Mitochondrion; M1 
spastin, isoform M1 of the microtubule-severing protein spastin; Pex, Peroxin; PI(4,5)P2, 
Phosphatidylinositol-4,5-biphosphate; PO, Peroxisome; Syt7, Synaptogamin-7; VAPB, Vesicle-
Associated Membrane Protein (VAMP)-associated Protein B. 
Figure 3. Schematic overview of Golgi-ER and plasma membrane-organelle interactions 
and their physiological relevance. CERT, Ceramide Transport Protein; FAPP1 – Phosphatadyl-
four-phosphate-adaptor protein 1; ER, Endoplasmic Reticulum; GOLGI, Golgi Apparatus; 













cortex anchor; MITO, Mitochondrion; Num1, Nuclear migration protein 1; Orai1, Calcium 
release-activated calcium channel protein 1; Orp, Oxysterol-binding protein related protein; 
Osbp, Oxysterol-binding protein; Osh, Oxysterol-binding protein homology; PI(4)P-
Phosphatidylinositol-4-phosphate; Sac1, suppressor of actin 1; Scs2, suppressor of chromosome 
segregation protein 1 (CSE1) 2; STIM1, Stromal Interaction Molecule 1; VAP, Vesicle-
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Organelles (MCS) MCS Components* Physiological role  References 




SEL1L (ER)  




Spire1C (MITO) – 
INF2 (ER) tether 
 [45-47] 
IP3R (ER) – GRP75 
















homeostasis in mammalian 
neurons? 
[60,62] 







VPS13A (MITO) – 
VAP (ER)  
Lipid transfer [73,127] 




the ER to MITO 
[78,79] 
NLRP3 (ER) – 
MAVS (MITO)  
Immune signalling and 
inflammation 
[82-85] 
PTPIP51 (MITO) – 








STARD3 (LYS) – 
tether?  
Cholesterol transport to 
MITO (compensatory 

















Regulated by RAB7, 
TBC1D15 (binds 




Iron transport from 
ENDO/LYS to MITO 
[119-122] 




Lipid transfer between LD 




Regulated by AMPK   [124] 
DGAT2 (ER/LD), 
FATP1 (ER)  




(MITO) – PLIN5 
(LD)  




MIGA2 (MITO) – 
Unknown protein 
(LD), VAPB (ER) 
















Organelles (MCS) MCS 
Components* 
Physiological role  References 






Coordination of fatty 
acid β-oxidation (PO) 
and elongation (ER); 
lipid transfer for ether-
phospholipid synthesis; 
(phospho)lipid transfer 
for PO biogenesis (PO 
membrane expansion; 
regulation of PO 
positioning and mobility 
[149-151] 
Lipid synthesis for virus 
replication 
[171] 
PI(4,5)P2 (PO) – E-
SYTs  
Transport of cholesterol [208] 
ABCD3 (PO) – 
ATF6α (ER) tether  
Regulation of ER stress; 
control of cellular stress 
response 
[167] 
Pex3 (PO/ER) – 
Inp1 tether (yeast) 
PO inheritance in yeast; 
control of PO abundance 
[147,148] 
Pex24, Pex32 (ER) 
– Pex11 (PO) tether 
(yeast) 
PO biogenesis and 
proliferation; positioning 
at the cell cortex; proper 
segregation to mother 
cells and buds 
[146] 
Peroxisomes – Lipid Droplets
 
ABCD1 (PO) – M1 
spastin (LD) tether, 
ESCRTIII proteins 
IST1 and CHMP1B 
(LD) 
Fatty acid trafficking 
between LDs and PO; 
lipolysis 
[178] 
Peroxisomes – Mitochondria Pex11 (PO) – 
Mdm34 (ERMES, 
MITO) (yeast) 

















Regulation of fatty acid 












PI(4,5)P2 (PO) – 
SYT7 (LYS) tether  
Cholesterol transport 
from LYS to PO 
[208] 








PO movement via 
endosome ‗hitch-hiking‘ 
[214,215] 



















Organelles (MCS) MCS Components* Physiological role  References 
Golgi Complex – 
Endoplasmic Reticulum 
 
PI(4)P (TGN) – 
OSBP1/ORP9/10/11 – 
VAP (ER) 
Direct transport of sterols [20,220,223-
225] 
PI(4)P (TGN) – CERT – 
VAP (ER) 
Translocation of ceramide 
from ER to TGN 
[219,227] 
PI(4)P (TGN) – FAPP1 
– SAC1 (ER) – VAP 
(ER) 
PI4P homeostasis [229] 




Osh2/3 (PM) – VAP 
(ER) tether (?) (yeast) 
Transport of sterols from the 
ER to the PM in yeast 
[234] 
Scs2/Scs22 (ER), Sac1 
(ER), Ist2 (ER), 








between the ER and the PM. 
[240,241] 









Plasma Membrane – 
Mitochondria
PI(4,5)P2 (PM) – Num1 
– Mdm36 
(MITO)/cardiolipin 
(MITO)/Scs2 (ER) tether 
(= MITO-PM-ER triple 
contact)  
(yeast) 
MITO inheritance; regulation 



















MFN1 (MITO) – PKCζ 
(PM) tether (?) 
Epithelial-mesenchymal 
transition (EMT) in mammals. 
[257] 























Declaration of interests 
 
☒ The authors declare that they have no known competing financial interests or personal relationships 
that could have appeared to influence the work reported in this paper. 
 
☐The authors declare the following financial interests/personal relationships which may be considered 

























 Membrane contact sites (MCSs) physically and functionally link organelles 
 MCSs are ubiquitous, diverse and dynamic 
 Mitochondria, ER, peroxisomes, Golgi and plasma membrane all form numerous MCSs 
 MCSs facilitate intracellular signalling, lipid and metabolite transfer 
 MCSs are important for organelle dynamics, division and inheritance 
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